Presentations: Leipzig Interventional Course – interdisciplinary global platform for endovascular interventions

Conference day 1

Tuesday, January 30th 2018

8:00 - 9:30, Room 1 - Main Arena 1

SYMPOSIUM: Present and future clinical use for vascular mimetic stents

supported with an educational grant from Abbott Vascular

Moderator:

Dierk Scheinert

Panel:

Enrique San Norberto-García, Jörg Teßarek, Peter Goverde
1. 08:00 - 08:07
  
  2-year data Supera popliteal real world
2. 08:07 - 08:14
  
  Supera in popliteal aneursym
3. 08:14 - 08:45
  
  Live case transmission from Leipzig
4. 08:45 - 08:52
  
  Preliminary 6-month results of VMI CFA trial
5. 08:52 - 08:59
  
  NEW DAWN: 1-year results of the combination DCBs and Supera stent for the treatment of long femoropoliteal lesions
6. 08:59 - 09:30
  
  Live case transmission from Leipzig
8:00 - 9:30, Room 2 - Main Arena 2

Acute deep vein thrombosis

Moderator:

Stephen Black, Michael Lichtenberg

Panel:

Jörn Dopheide, Christian Erbel
1. 08:00 - 08:10
  
  Pharmacomechanical thrombolysis
2. 08:10 - 08:20
  
  Catheter-directed thrombolysis
3. 08:20 - 08:30
  
  Catheter treatment of DVT: What do the guidelines say?
4. 08:30 - 08:40
  
  The ATTRACT study: View from the U.S. expert
5. 08:40 - 08:50
  
  The ATTRACT study: View of a European expert
6. 08:50 - 09:10
  
  Live case transmission from Zurich
7. 09:10 - 09:30
  
  Live case transmission from Galway
8:00 - 18:00, Scientific Posters

Electronic posters will be displayed from 08:00 – 18:00 in front of Main Arena 1
9:00 - 11:00, Room 3 - Technical Forum

Management of carotid artery disease: Remaining controversies and challenges ahead

Moderator:

Marc van Sambeek, William Gray

Panel:

Carlo Setacci, Stanislaw Bartus, Steve Ramee
1. 09:00 - 09:07
  
  Randomised data in carotid artery stenting: current evidence and future perspectives
2. 09:07 - 09:12
  
  Despite Level 1 and other evidence, the future outlook for carotid stenting is bright
3. 09:12 - 09:19
  
  The future of carotid stenting – Proximal protection and mesh-covered stents are the answer
4. 09:19 - 09:44
  
  Live case transmission from Berlin
5. 09:44 - 09:51
  
  1-year results of a new mesh-covered carotid stent: SCAFFOLD trial
6. 09:51 - 09:58
  
  The CLEAR-ROAD study: a physician-initiated study investigating the RoadSaver stent in carotid lesions (final 12-month results)
7. 09:58 - 10:05
  
  PrOspective multiCentrE study of cArotid artery steNting Using MER Stent – the OCEANUS study
8. 10:05 - 10:12
  
  Comparative analysis of new mesh-covered stent designs using MRI parameters
9. 10:12 - 10:19
  
  Plaque protrusion during carotic artery stenting: risk factors determined by MR plaque imaging
10. 10:19 - 10:26
  
  ROADSTER 2 trial: Transcervical access with reversed flow circuit for proximal protection during CAS. What have we learned so far?
11. 10:26 - 10:33
  
  Transcervical carotid stenting (TECAR) with flow reversal vs. CEA in highly symptomatic patients
12. THE GREAT DEBATE: HOW SHOULD WE HANDLE ASYMPTOMATIC CAROTID STENOSES?
13. 10:33 - 10:40
  
  Carotid repair is best for asymptomatic severe carotid stenosis because medical management alone does not work
14. 10:40 - 10:47
  
  When better NOT to treat asymptomatic carotid stenosis
15. 10:47 - 10:54
  
  ACST-2, over 2500 patients randomised; what do we know?
16. 10:54 - 11:00
  
  Discussion and conclusion
9:30 - 11:00, Room 1 - Main Arena 1

Latest results with new technologies for femoropopliteal obstructions: drug-eluting devices, atherectomy and new implants

Moderator:

Dierk Scheinert

Panel:

Marianne Brodmann, Thomas Zeller, Steven Kum, Wei Guo
1. 09:30 - 09:35
  
  EFFPAC–RCT: Final 6-months results with the Luminor DCB in femoropopliteal lesions
2. 09:35 - 09:40
  
  ILLUMENATE EU RCT: 2-year results with the Stellarex DCB in femoropopliteal lesions
3. 09:40 - 09:45
  
  FIRST TIME DATA RELEASE: CONSEQUENT RCT: 2-year results with the SeQuent Please OTW DCB
4. 09:45 - 09:50
  
  FIRST TIME DATA RELEASE: IN.PACT Japan RCT of DCB vs. PTA: 2-year results
5. 09:50 - 09:55
  
  FIRST TIME DATA RELEASE: ILLUMENATE GLOBAL: 2-year results of the Stellarex DCB in femoropoliteal lesions
6. 09:55 - 10:00
  
  DANCE trial (ATX and PTA groups) – 2-year results
7. 10:00 - 10:05
  
  Long term durability of DCB treatment in the SFA: 4-year results of the IN.PACT SFA study
8. 10:05 - 10:10
  
  Outcomes of DCB use in real-world patients: 2-year results from the IN.PACT global registry
9. 10:10 - 10:15
  
  FIRST TIME DATA RELEASE: LUTONIX long lesion study: 2-year outcomes
10. 10:15 - 10:20
  
  FIRST TIME DATA RELEASE: COMPARE-Pilot RCT: 1-year results of a randomised comparison of RANGER DCB vs. IN.PACT DCB in complex SFA lesions
11. 10:20 - 10:25
  
  FIRST TIME DATA RELEASE: Outcomes of DCB use in femoropopliteal lesions of patients with CLI (RCC4/5): Subgroup analysis of IN.PACT global study
12. PROMISE AND LIMITATIONS OF DCB – WHAT HAVE WE LEARNED?
13. 10:25 - 10:30
  
  DCB from a preclinical perspective: The relevance of paclitaxel dose and coating integrity
14. 10:30 - 10:35
  
  DCB from a clinical perspective: What is proven and where are the open questions and limitations?
15. 10:35 - 10:40
  
  Panel discussion
16. 10:40 - 10:45
  
  Update on the TOBA studies in the femoropopliteal arteries
17. 10:45 - 10:50
  
  FIRST TIME DATA RELEASE: LOCOMOTIVE All Comers Study with the VascuFlex Multi-LOC spot stenting device: 12-month results
18. 10:50 - 10:55
  
  FIRST TIME DATA RELEASE: 1-year results from the MIMICS-2 Study; US, German, and Japanese experience with the BioMimics 3D stent
19. 10:55 - 11:00
  
  Discussion and conclusion
9:30 - 11:00, Room 2 - Main Arena 2

Management of complex aortoliliac disease: Avoiding complications and optimizing outcomes

Moderator:

Lawrence Garcia, Ramon Varcoe

Panel:

Patrice Mwipatayi, Jörn Balzer, Peter Goverde, Chris Metzger
1. 09:30 - 09:36
  
  Endovascular treatment of occlusive aortic disease with abdominal stent grafts
2. 09:36 - 09:42
  
  Contemporary stenting of the abdominal aorta for steno-occlusive disease: new technical developments
3. 09:42 - 09:47
  
  Mid-term outcome of CERAB for aorto-iliac occlusive disease
4. 09:47 - 10:10
  
  Live case transmission from Cotignola
5. 10:10 - 10:16
  
  Experience after 500 endoluminal stent grafts. Devices specific outcome and lessons learned.
6. 10:16 - 10:21
  
  LIFESTREAM™ – First look at the BOLSTER two year follow up data
7. 10:21 - 10:26
  
  Improving the treatment of complex iliac occlusive disease: 24-month results from the VBX FLEX trial show sustained clinical benefits in complex patient subsets
8. 10:26 - 10:54
  
  Live case transmission from Leipzig
9. 10:54 - 11:00
  
  Prevention and management of vascular complications related to transcatheter aortic valve implantation
10:30 - 12:00, Room 5 - Global Expert Exchange

CCT@LINC

Moderator:

Giancarlo Biamino, Kazushi Urasawa

Panel:

Hiroshi Ando, Tatsuya Nakama, Osamu Iida
1. 10:30 - 10:40
  
  Introduction
2. 10:40 - 10:55
  
  Video live and lecture: How to cross below-the-knee CTO
3. 10:55 - 11:10
  
  Video live and lecture: How to cross below-the-ankle CTO
4. 11:10 - 11:25
  
  Video live and lecture: How to cross SFA CTO/Japanese evidences
5. 11:25 - 11:40
  
  Video live and lecture: How to cross SFA CTO/Japanese techniques
6. 11:40 - 12:00
  
  Discussion and conclusion
11:00 - 12:30, Room 1 - Main Arena 1

SYMPOSIUM: Patient first: “Leave the right thing behind”. Debating evidence to provide the answers

supported with an educational grant from COOK Medical

Moderator:

Iris Baumgartner-Peuker

Panel:

Thomas Zeller, Fabrizio Fanelli, Aloke Finn, Marc Bosiers
1. 11:00 - 11:05
  
  Introduction
2. 11:05 - 11:13
  
  XPEDITE study
3. 11:13 - 11:21
  
  DCB + BMS is not a DES
4. 11:21 - 11:41
  
  Live case transmission from Leipzig
5. 11:41 - 11:49
  
  Understanding restenosis in the SFA
6. 11:49 - 11:57
  
  First results of the ZILVERPASS study
7. 11:57 - 12:17
  
  Live case transmission from Jena
8. 12:17 - 12:25
  
  The importance of scientific evidence
9. 12:25 - 12:30
  
  Summing up on symposium discussion and debate
11:00 - 12:30, Room 2 - Main Arena 2

Venous stenting

Moderator:

Houman Jalaie, Robert Lookstein

Panel:

Michael Lichtenberg, Christian Erbel
1. 11:00 - 11:15
  
  Live case transmission from Zurich
2. 11:15 - 11:30
  
  Live case transmission from Galway
3. 11:30 - 11:40
  
  Clinical results of venous stents
4. 11:40 - 11:50
  
  Clinical results of a dedicated May Thurner stent
5. 11:50 - 12:00
  
  Anticoagulation after stenting for acute deep vein thrombosis
6. 12:00 - 12:15
  
  Live case transmission from Zurich
7. 12:15 - 12:30
  
  Live case transmission from Galway
11:00 - 12:30, Room 3 - Technical Forum

The challenge ahead: How to improve acute stroke management

Moderator:

William Gray, Karl-Titus Hoffmann

Panel:

Marco Roffi, Bernhard Reimers
1. 11:00 - 11:07
  
  Periprocedural neurologic complications during CAS: How to manage
2. 11:07 - 11:14
  
  Acute stroke management – What is state of the art?
3. 11:14 - 11:21
  
  Acute stroke treatment: How I do it
4. 11:21 - 11:26
  
  A single centre experience in stroke treatment with EmboTrap II: Technology based on Clot research
5. 11:26 - 11:36
  
  Case reviews
6. 11:36 - 11:43
  
  Reality of stroke management in Germany and how to proceed
7. 11:43 - 11:50
  
  From interventional cardiology to cardio-neurology. A new sub-speciality in the future?
8. 11:50 - 12:16
  
  Live case transmission from Cotignola
9. 12:16 - 12:23
  
  Early results of the PERFORMANCE I study assessing the safety and feasibility of a 3-in-1 carotid stenting sytem with integrated embolic protection
10. 12:23 - 12:30
  
  Experience with bilateral carotid filter protection during percutaneous aortic valve replacement
12:30 - 13:30, Room 1 - Main Arena 1

Lunch
12:30 - 13:25, Room 2 - Main Arena 2

LUNCH SYMPOSIUM: Vascular protection in patients with peripheral artery disease (PAD): Improving outcomes with dual pathway inhibition – The COMPASS study

supported with an educational grant from Bayer AG

Moderator:

Dierk Scheinert

Panel:

Sebastian Debus, Uwe Zeymer, Rupert Bauersachs
1. 12:30 - 12:35
  
  Opening remarks
2. 12:35 - 12:45
  
  Vascular protection in patients with CAD and PAD: New options
3. 12:45 - 12:55
  
  From registries to clinical trials: impact on guidelines for PAD
4. 12:55 - 13:10
  
  PAD: From post-intervention to the chronic state
5. 13:10 - 13:25
  
  Question and Answer
12:30 - 13:30, Room 4 - Discussion Forum

My selection of guidewire and support catheter for complex BTK procedures

supported with an educational grant from Asahi Intecc

Moderator:

Kazushi Urasawa
1. Guide wire selection
2. Guide wire selection
3. Support catheter selection
12:30 - 13:30, Room 6 - Speakers' corner

Update on clinical trials and new data – PVD/ BTK/ CLI

Moderator:

Jihad Mustapha

Panel:

Miguel Montero-Baker, Steven Kum
1. 12:30 - 12:35
  
  36-month results from the absorb BTK study
2. 12:35 - 12:40
  
  6-month results of real-life use of the latest generation of balloon expandable DES in below-the-knee treatment
3. 12:40 - 12:45
  
  Below-the-knee balloon angioplasty with and without non-selective stem cells infusion in treatment of critical limb ischemia
4. 12:45 - 12:50
  
  Statin therapy and amputation-free survival in CLI patients: insights from the CRITISCH registry
5. 12:50 - 12:55
  
  Peroneal artery angioplasty as a single runoff vessel for foot revascularisation in patients with critical limb ischemia
6. 12:55 - 13:00
  
  Real-world experience with a paclitaxel-coated balloon for the treatment of atherosclerotic infrainguinal arteries. 12-month results of the BIOLUX P-III all comers registry in critical limb ischemia patients
7. 13:00 - 13:05
  
  1-year outcomes of peripheral vascular intervention in critical limb ischemia patients: Sub-analysis of the LIBERTY 360 study
8. 13:05 - 13:10
  
  Update on the BEST-CLI trial
9. 13:10 - 13:15
  
  The relation of 2D perfusion angiography after below-the-knee intervention and wound healing in patients with critical limb ischemia – single center prospective study
10. 13:15 - 13:20
  
  Interim results from the OMNIA study – utilisation of micro oxygen sensors during CLI therapy
11. 13:20 - 13:30
  
  Discussion and conclusion
12:30 - 13:30, Room 7 - Speakers' corner

Selected abstracts original research – EVAR part I

Moderator:

Weiguo Fu

Panel:

Ralph-Ingo Rückert, Ramon Varcoe
1. 12:30 - 12:35
  
  Cardiac- and respiratory-induced motion of renal arteries and stents in snorkel endovascular aneurysm sealing
2. 12:35 - 12:40
  
  30-day mortality and re-interventions after open and endovascular repair of intact and ruptured abdominal aortic aneurysms in Korea: Based on HIRA data
3. 12:40 - 12:45
  
  Outcomes after one-stage vs. two-stage open repair of Type II thoracoabdominal aortic aneurysm
4. 12:45 - 12:50
  
  The impact of endovascular aneurysm repair on short and long term renal function
5. 12:50 - 12:55
  
  Total endovascular techniques utilisation in aortic dissection radical treatment
6. 12:55 - 13:00
  
  A single center experience using automated intracranial pressure-controlled cerebrospinal fluid external drainage
7. 13:00 - 13:05
  
  Endovascular treatment of giant abdominal aortic aneurysms
8. 13:05 - 13:10
  
  Effect of remote ischemic preconditioning in the incidence of contrast induced nephropathy in patients undergoing EVAR (RIP-EVAR STUDY)
9. 13:10 - 13:15
  
  12-year experience with the treatment of aortoiliac and isolated iliac aneurysms by the iliac branch devices: Results of the pELVIS registry
10. 13:15 - 13:20
  
  The Image-Fusion using 2D-3D registration method helps to reduce the used contrast medium, fluoroscopic, and procedural time in TEVAR procedures
11. 13:20 - 13:30
  
  Discussion and conclusion
12:35 - 13:20, Room 3 - Technical Forum

LUNCH SYMPOSIUM: Unmet needs in EVAR: do they exist?

supported with an educational grant from Cardinal Health

Moderator:

Giovanni Torsello

Panel:

Giovanni Pratesi, Jean-Pierre Becquemin
1. 12:35 - 12:52
  
  Unmet needs in EVAR: case and discussion
2. 12:52 - 13:09
  
  Percutaneous technique for EVAR: case and discussion
3. 13:09 - 13:16
  
  Latest clinical results from INCRAFT™ AAA Stent Graft – 5 years of data
4. 13:16 - 13:20
  
  Discussion and conclusion
12:35 - 13:20, Room 5 - Global Expert Exchange

LUNCH SYMPOSIUM: DCB or stent? The latest data to influence your decision

supported with an educational grant from iVascular

Moderator:

Koen Deloose
1. 12:35 - 12:43
  
  Luminor DCB makes it different and favourable in CLI (LUMINOR registry, 12-month data)
2. 12:43 - 12:51
  
  Is there still any space left for DES? (ANGIOLITE BTK trial, 6-month data)
3. 12:51 - 12:58
  
  Discussion: BTK
4. 12:58 - 13:06
  
  Is Luminor DCB the best choice for femoropopliteal lesions? (EFFPAC–RCT, 6-month data)
5. 13:06 - 13:14
  
  Or is the iVolution stent a better alternative? (EVOLUTION study, 12-month data)
6. 13:14 - 13:20
  
  Femoropopliteal arteries discussion
13:00 - 14:40, Scientific Posters

Moderated poster round: Challenging cases: AV, iliac, venous

Juror:

Christian Erbel, Marcus Treitl
1. 13:00 - 13:05
  
  Acute thrombosis complicating aneurysmal fistula salvage
2. 13:05 - 13:10
  
  Endovascular management for salvage of arteriovenous fistula
3. 13:10 - 13:15
  
  Bilateral endovascular interventions after crossover bypass grafting
4. 13:15 - 13:20
  
  Persistent sciatic artery aneurysm, case report and follow-up for 15 years
5. 13:20 - 13:25
  
  Successful of hybrid revascularisation for TASC D AIOD after failing femoro-femoral crossover bypass
6. 13:25 - 13:30
  
  Percutaneous revascularization could be a feasible option for complex aorto-iliac occlusive disease (case presentation)
7. 13:30 - 13:35
  
  Complex ilio-femoral revascularization with a Gore® Hybrid Vascular Graft
8. 13:35 - 13:40
  
  Endovascular treatment of calcified, stenotic iliac arteries
9. 13:40 - 13:45
  
  Innovative use of covered stents in acute lower limb ischaemia due to aorto iliac occlusions – two case reports
10. 13:45 - 13:50
  
  Guidewire related complication during hemodialysis catheter placement: Intravascular knotted guidewire
11. 13:50 - 13:55
  
  Superior vena cava filter placement for prevention of pulmonary embolism due to acute upper extremity deep venous thrombosis in patients contra-indicated anticoagulation
12. 13:55 - 14:00
  
  Catheter directed thrombolysis for treatment of bilateral Iliofemoral deep venous thrombosis with hypoplastic inferior vena cava
13. 14:00 - 14:05
  
  Endovascular Treatment of deep venous thrombus due to May-Thurner syndrome using self-expandable stents. 4 case series with intravascular ultrasound findings
14. 14:05 - 14:10
  
  Acute deep vein thrombosis with duplication of inferior vena cava
15. 14:10 - 14:15
  
  Successful treatment of acute thrombosis (2 days ago) of left subclavian vein with initial chronic occlusion of the left brachiocephalic vein by combination CDT and balloon angioplasty described veins
16. 14:15 - 14:20
  
  A case of successful endovascular treatment of acute BT-shunt thrombosis
17. 14:20 - 14:25
  
  A successful intervention with catheter-directed thrombolysis for patient with upper-extremity deep vein thrombosis
18. 14:25 - 14:30
  
  Reconstruction of acquired IVC interruption
19. 14:30 - 14:35
  
  Endoprosthesis and hypogastric thrombosis after prothrombin complex concentrate administration – a real nightmare
20. 14:35 - 14:40
  
  Endovascular solution to a tumor-induced occlusion of iliac vessels
13:30 - 15:00, Room 1 - Main Arena 1

Leave nothing behind 2.0: Combination therapy to advance SFA treatment strategy

supported with an educational grant from Medtronic

Moderator:

Dierk Scheinert

Panel:

Krishna Rocha-Singh, Wei Guo
1. 13:30 - 13:35
  
  Introduction
2. 13:35 - 13:45
  
  SFA disease management: Are the longterm outcomes with IN.PACT DCB changing the peripheral landscape?
3. 13:45 - 14:05
  
  Live case transmission from New York
4. 14:05 - 14:15
  
  Dose matters: Understanding the science behind DCB outcomes
5. 14:15 - 14:25
  
  From Chocolate to Hawk: Vessel preparation for improved outcomes
6. 14:25 - 14:45
  
  Live case transmission from Cotignola
7. 14:45 - 15:00
  
  Discussion and conclusion
13:30 - 15:00, Room 2 - Main Arena 2

SCRUB-IN WITH THE EXPERTS: Endovascular therapy of chronic deep vein obstructions

live from Zurich:

Nils Kucher

live from Galway:

Gerard O'Sullivan

Moderator:

Erin Murphy

Panel:

Yvonne Bausback, Stephen Black, Rick de Graaf, Tim Sebastian, Houman Jalaie
1. FLASH PRESENTATION: Complex iliocaval reconstruction with steel alloy stents
2. FLASH PRESENTATION: Complex iliocaval reconstruction with nitinol stents
3. FLASH PRESENTATION: Endophlebectomy of the common femoral vein
13:30 - 15:00, Room 3 - Technical Forum

SCRUB-IN WITH THE EXPERTS: Focus on vessel preparation and stenting strategies for complex lesions

partially supported with an educational grant from B. Braun

live from Leipzig:

Andrej Schmidt, Sven Bräunlich

Moderator:

Tony Das, Torsten Fuß

Panel:

Klaus Amendt, Brian DeRubertis, Ulf Teichgräber
1. FLASH PRESENTATION: Vessel preparation prior to DCB or stenting: How to do it
2. 13:45 - 13:50
  
  Clinical benefits of the Vanguard IEP peripheral balloon angioplasty system with integrated embolic protection from the ENTRAP study
3. 13:50 - 14:00
  
  Recorded case presentation: DETOUR procedure overview
4. SPOT STENTING & DCB: IT'S TIME TO UNDRESS THE FULL METAL JACKET
5. FLASH PRESENTATION: Fempop treatment: Long stents vs. short stents
6. FLASH PRESENTATION: Spot stenting with VascuFlex Multi-LOC
7. FLASH PRESENTATION: Combination therapy: DCB & spot stents in fempop lesions
13:30 - 14:30, Room 4 - Discussion Forum

New GORE® VIABAHN® VBX Balloon Expandable: Expert forum

supported with an educational grant from Gore & Associates

Moderator:

Andrew Holden
1. Advantages of an indication for the GORE® VIABAHN® VBX Balloon Expandable: technical and clinical value in treating aorto-iliac disease
2. Results from the VBX the IDE study and case experience
3. Case experience in aortic disease
4. Discussion
13:30 - 15:00, Room 5 - Global Expert Exchange

Clinical approaches and techniques in the management of CLI diabetic patients

partially supported with an educational grant from Alvimedica

Moderator:

Marco Manzi, Gary Ansel

Panel:

Eric Ducasse, Francesco Liistro
1. 13:30 - 13:38
  
  The specifics of diabetic macroangiopathy: What is different from atherosclerosis and how does it contribute to critical limb ischemia?
2. 13:38 - 13:44
  
  The multidisciplinary approach in BTK intervention in DM patients: the right road to success
3. 13:44 - 13:50
  
  Factors affecting outcome of CLI procedures
4. 13:50 - 13:56
  
  Timing is all in CLI diabetic patients: planning a winning strategy for limb salvage
5. 13:56 - 14:16
  
  Live case transmission from Berlin
6. 14:16 - 14:24
  
  Latest techniques and results in BTK interventions
7. DEBATE ON STUDY RESULTS VS. DAILY PRACTICE IN BTK INTERVENTIONS:
8. 14:24 - 14:30
  
  Use of DCB in BTK – CONTRA
9. 14:30 - 14:36
  
  Use of DCB in BTK – PRO
10. 14:36 - 14:42
  
  Use of DES in BTK – CONTRA
11. 14:42 - 14:48
  
  Use of DES in BTK – PRO
12. 14:48 - 14:54
  
  Is 2018 the right moment to try to harmonize BTK intervention approaches?
13. 14:54 - 15:00
  
  Are the coronary outcomes of BVS relevant to BTK applications?
13:30 - 15:00, Room 6 - Speakers' corner

Update on clinical trials and new data – PVD/ aortoiliac/ femoral

Moderator:

Oliver Schlager

Panel:

Theodosios Bisdas, Marcus Thieme
1. 13:30 - 13:35
  
  Midterm outcome of the covered endovascular reconstruction of the aortic bifurcation (CERAB) technique for aortoiliac occlusive disease
2. 13:35 - 13:40
  
  The BeGraft study: A physician-initiated study investigating the BeGraft peripheral stent graft in the iliac arteries (final 24-month results)
3. 13:40 - 13:45
  
  XTRACT as a potential frontline treatment in peripheral arterial thromboembolism – results from the multicenter PRISM trial
4. 13:45 - 13:50
  
  Impact of patient and lesion characteristics on drug coated balloon angioplasty of the femoro-popliteal artery – pooled analysis of four randomized controlled multicentre trials
5. 13:50 - 13:55
  
  Local and distal ptx effect: pre-clinical results with different DCBs
6. 13:55 - 14:00
  
  Long term results of >200 patients with the Aperto® DCB from the Italian Aperto registry
7. 14:00 - 14:05
  
  Interim report of the BIOFLEX-COF RCT, comparing high vs. low chronic outward force of nitinol stents in the SFA
8. 14:05 - 14:10
  
  A French experience of ambulatory intervention for endovascular treatment of peripheral artery disease: a retrospective study
9. 14:10 - 14:15
  
  A randomised comparison of digital subtraction angiography and kinetic imaging
10. 14:15 - 14:20
  
  The influence of balloon inflation time in femoropopliteal and BTK angioplasty: a systematic review
11. 14:20 - 14:25
  
  Tibial velocities duplex ultrasound characterisation and validity of the ankle-deep femoral artery index in peripheral arterial disease
12. 14:25 - 14:30
  
  Use of Paclitaxel-Coated Luminor® balloon catheter in the superficial femoral and popliteal arteries – the solo DEB registry
13. 14:30 - 14:35
  
  BIOFLEX – PEACE registry 24-month analysis
14. 14:35 - 14:40
  
  The Münster all-comers registry of Eluvia drug-eluting stent: 1-year outcomes
15. 14:40 - 14:45
  
  BATTLE RCT. Bare metal stent vs. drug eluting stent for SFA intermediate lesions. 6-month results
16. 14:45 - 14:50
  
  Interim 30-day analysis from the KANSHAS 1 study of the novel KANSHAS drug coated balloon for treatment of femoropopliteal occlusive disease; a latest first-in-human study
17. 14:50 - 14:55
  
  Peripheral aneurysm coiling using large volume ruby coils: Results from the multicenter ACE registry
18. 14:55 - 15:00
  
  Discussion and conclusion
13:30 - 15:00, Room 7 - Speakers' corner

Selected abstracts original research – EVAR part II

Moderator:

Marc van Sambeek

Panel:

Wolfgang Ritter
1. 13:30 - 13:35
  
  Deployment of bare stent reduce the pressure of false lumen in acute aortic dissection: Animal model and computer simulation
2. 13:35 - 13:40
  
  Complications in target arteries of branched and fenestrated stent grafts – incidence and management
3. 13:40 - 13:45
  
  Thirty day outcomes favor fenestrated repair of complex abdominal aortic aneurysms
4. 13:45 - 13:50
  
  Initial experience with the E-Iiac® iliac branch device for the endovascular aortic repair of aorto-iliac aneurysms
5. 13:50 - 13:55
  
  Open repair of proximal abdominal aneurysms classified according to the equivalent fenestrated endovascular treatment
6. 13:55 - 14:00
  
  Individualised patient decision making promotes favorable outcomes in endovascular therapy for blunt traumatic aortic injury
7. 14:00 - 14:05
  
  Mid-term outcomes of flared iliac limb used for combined common iliac artery aneurysm during endovascular aneurysm repair
8. 14:05 - 14:10
  
  The Candy-Plug technique using an Excluder aortic cuff – clinical utility and technical aspects
9. 14:10 - 14:15
  
  Evaluation of visible spinal arteries on CT angiography before and after branched stent graft repair for thoracoabdominal aortic aneurysm
10. 14:15 - 14:20
  
  Aneurysm of visible spinal arteries on CT angiography before and after branched stent graft repair for thoracoabdominal aortic aneurysm
11. 14:20 - 14:25
  
  Outcome of thoracic endovascular aortic repair with single aortic arch chimney in high risk patients
12. 14:25 - 14:30
  
  The outcome of the AFX ENDOLOGIX endograft in the prevention of Type II endoleak
13. 14:30 - 14:35
  
  Endovascular treatment of thoracoabdominal aortic aneurysm using multi-branched stent-grafts in the real world
14. 14:35 - 14:40
  
  How we deal with aortic endograft infection
15. 14:40 - 14:45
  
  Immediate, delayed, and late spinal cord ischemia after extended endovascular thoracoabdominal aortic repair
16. 14:45 - 15:00
  
  Discussion and conclusion
14:45 - 16:05, Scientific Posters

Original research: AV, iliac, renal, venous and miscellaneous

Juror:

Steve Ramee, Eberhard Wedell
1. 14:45 - 14:50
  
  10 year follow up of thrombosed AV fistula salvage: An endovascular first approach
2. 14:50 - 14:55
  
  Endovascular management of failing arteriovenous fistula
3. 14:55 - 15:00
  
  Balloon-assisted AV access maturation
4. 15:00 - 15:05
  
  Short-term outcomes of endovascular treatment of aorto-iliac occlusive disease
5. 15:05 - 15:10
  
  Comparison of standard renal denervation procedure versus novel distal and branch vessel procedure with brachial arterial access
6. 15:10 - 15:15
  
  Urgent endovascular treatment of renal hemorrage: our experience in the last 5 years
7. 15:15 - 15:20
  
  Clinical and procedural outcomes between ultra-sound accelerated thrombolysis and catheter directed thrombolysis for treatment of acute pulmonary embolism
8. 15:20 - 15:25
  
  Efficacy and safety of duplex-guided polidocanol foam sclerotherapy for venous malformations
9. 15:25 - 15:30
  
  The cost-saving potential of endovenous laser ablation (ETA) of truncal varicose veins in Switzerland
10. 15:30 - 15:35
  
  Impact of training on endovascular interventions for thrombosis in large veins
11. 15:35 - 15:40
  
  Role of Inferior vena cava filter insertion prior to thrombolysis of acute ilio femoral deep venous thrombosis
12. 15:40 - 15:45
  
  Skipped lesion at Iliocaval confluence: another technique for stenting in chronic venous obstructions
13. 15:45 - 15:50
  
  Detecting stent geometry changes after venous recanalisation using duplex ultrasound
14. 15:50 - 15:55
  
  Endovascular treatment of visceral artery aneurysm – a single center experience
15. 15:55 - 16:00
  
  A novel embolic with minimal catheter adhesion properties: GPX by Fluidx Medical Technology
16. 16:00 - 16:05
  
  Transcatheter plug occlusion for various complications after cardiac/thoracic aortic surgery
15:00 - 16:30, Room 1 - Main Arena 1

SYMPOSIUM: Going further with drug eluting technology in peripheral arterial disease: From SFA to below the knee challenges.

supported with an educational grant from Boston Scientific

Moderator:

Dierk Scheinert

Panel:

Marc Sapoval, Hans van Overhagen, Jihad Mustapha
1. 15:00 - 15:03
  
  Opening and learning objectives
2. 15:03 - 15:10
  
  Current data and performance of drug eluting technology in SFA
3. 15:10 - 15:17
  
  BTK intervention with drug coated balloons. Past lessons and future exploration
4. 15:17 - 15:47
  
  Live case transmission from Leipzig
5. 15:47 - 15:54
  
  Drug eluting stents in BTK intervention – a review
6. 15:54 - 16:01
  
  Next steps in drug eluting stent for BTK intervention
7. 16:01 - 16:08
  
  Clinical targets and patient outcome goals in BTK intervention
8. 16:08 - 16:25
  
  Panel discussion
9. 16:25 - 16:30
  
  Closing remarks
15:00 - 16:30, Room 2 - Main Arena 2

SYMPOSIUM: Nightmares in the cathlab – My worst case and how I solved it

supported with an educational grant from Terumo

Moderator:

Koen Deloose

Panel:

Yann Gouëffic, Andrea Kahlberg
1. 15:00 - 15:05
  
  Introduction
2. 15:05 - 15:25
  
  SFA with distal embolization case
3. 15:25 - 15:45
  
  FP cases
4. 15:45 - 16:05
  
  BTK CLI cases
5. 16:05 - 16:25
  
  CAS cases
6. 16:25 - 16:30
  
  Conclusions
15:00 - 16:30, Room 3 - Technical Forum

SYMPOSIUM: Minimal is optimal in SFA therapy, reducing metal burden

supported with an educational grant from BIOTRONIK

Moderator:

Jos van den Berg

Panel:

Claus Nolte-Ernsting, Lieven Maene
1. 15:00 - 15:05
  
  Introduction by the moderator
2. 15:05 - 15:15
  
  BIOLUX P-III: Passeo-18 Lux all-comers registry: 12-month results for the all-comers cohort
3. 15:15 - 15:25
  
  BIOFLEX PEACE: Pulsar-18 all-comers registry: 12- and 24-month results
4. 15:25 - 15:45
  
  Live case transmission from Berlin
5. 15:45 - 15:55
  
  BIOLUX 4EVER: Combining Passeo-18 Lux DCB and Pulsar-18 BMS: 12-month results of full cohort
6. 15:55 - 16:15
  
  Live case transmission from Leipzig
7. 16:15 - 16:25
  
  BIOTRONIK REACT: REsponse Adapted Combination Therapy: When and where to stent – concept for a pilot study
8. 16:25 - 16:30
  
  Closing by the moderator
15:00 - 16:00, Room 4 - Discussion Forum

Technical and practical aspects of highend embolo therapy

sponsored by Medtronic

Moderator:

Walter Wohlgemuth, René Müller-Wille
1. Classification of vascular anomalies and its implication on therapies
2. Embolo therapy of peripheral AVMs
3. Treatment of pulmonary AVMs
4. Minimal invasive therapy of endoleaks
5. Discussion
15:00 - 16:30, Room 5 - Global Expert Exchange

CLI-Therapies-LINCed – Multidisciplinary case studies from centres of excellence

Moderator:

Marianne Brodmann, Steven Kum

Panel:

Osamu Iida, Michiel Schreve
1. MANAGING THE INFECTED WOUND
2. 15:00 - 15:12
  
  How do you prioritize revascularisation vs. treatment of infection – presentation and a case example
3. 15:12 - 15:18
  
  Questions and answers
4. ANGIOSOME DIRECTED THERAPY
5. 15:18 - 15:30
  
  Angiosome concept – myth or truth? Does it make a real difference in “real world” cases? Presentation and a case example
6. 15:30 - 15:36
  
  Questions and answers
7. THE "MOTHER OF ALL CLIs" – THE RUTHERFORD 6 WOUND
8. 15:36 - 15:48
  
  Managing R6 wounds – the utility of multi-vessel revascularisation and inflow strategies – presentation and a case example
9. 15:48 - 15:54
  
  Questions and answers
10. CLI IN DIALYSIS – A SPECIAL BREED OF PATIENTS
11. 15:54 - 16:06
  
  Plantar arch and below-the-ankle angioplasty – who, when, and how? Presentation and a case example
12. 16:06 - 16:12
  
  Questions and answers
13. END STAGE NO OPTION CLI – MAKING SWEET DESSERT OUT OF THE DESERT FOOT
14. 16:12 - 16:24
  
  Percutaneous deep venous arterialisation with the LimFlow procedure – presentation and a case example
15. 16:24 - 16:30
  
  Questions and answers
15:00 - 16:30, Room 6 - Speakers' corner

Update on clinical trials and new data – AV access/ venous/ embolisation/ EVAR

Moderator:

Konstantinos Katsanos

Panel:

Frans Moll, Jan Brunkwall
1. 15:00 - 15:05
  
  ACCESS PTS study: ACCElerated thrombolySiS for Post-Thrombotic Syndrome using the Acoustic Pulse Thrombolysis EkoSonic® Endovascular System – midterm results of a multi-center study.
2. 15:05 - 15:10
  
  Prospective, randomised controlled study of paclitaxel-coated vs. plain balloon angioplasty for the treatment of failing dialysis access
3. 15:10 - 15:15
  
  VasQTM improves functional maturation: Randomised controlled multinational study results
4. 15:15 - 15:20
  
  The Lutonix® global AV registry real world patients with a dysfunctional AV dialysis access – interim 6-month outcomes
5. 15:20 - 15:25
  
  DCB in vascular access – where does it work
6. 15:25 - 15:30
  
  AIDA study: prophylactic onlay mesh implantation prevents incisional hernia following AAA repair. Results from a multicenter randomised trial with 2-year follow up
7. 15:30 - 15:35
  
  Large access hole vascular closure device based on fully absorbable patch, results of the frontier III trial
8. 15:35 - 15:40
  
  Prevention of Acute Kidney Injury (AKI) following Endovascular Abdominal Aortic Aneurysm Repair (EVAR) using bicarbonate and aggressive hydration: the HYDRA-P randomised controlled trial
9. 15:40 - 15:45
  
  Prospective study of the E-liac stent graft system in patients with common iliac artery aneurysm: 12-month results
10. 15:45 - 15:50
  
  Global post-market clinical follow-up of the Treovance stent-graft for endovascular abdominal aortic aneurysm repair: final results from the RATIONALE registry
11. 15:50 - 15:55
  
  Anatomical applicability of current off-the-shelf branched endograft in thoracoabdominal aortic aneurysms managed by open surgery
12. 15:55 - 16:00
  
  A post-approval registry of the TREO stent-graft for patients with infrarenal abdominal aortic aneurysms
13. 16:00 - 16:05
  
  The Italian multi-centre experience of fenestrated Anaconda™ endograft for juxta/para-renal aortic aneurysms
14. 16:05 - 16:10
  
  The use of chimney grafts in the treatment of type Ia endoleaks after previous endovascular aneurysm repair: mid-term outcomes from the PERICLES registry
15. 16:10 - 16:30
  
  Discussion and conclusion
15:00 - 16:30, Room 7 - Speakers' corner

Selected abstracts original research – PVD/ BTK/ CLI

Moderator:

Iris Baumgartner-Peuker

Panel:

Sabine Steiner
1. 15:00 - 15:05
  
  Occlusion of the radial artery. Reality or myth
2. 15:05 - 15:10
  
  Multi-centre European experience in the use of the Indigo vacuum-assisted thrombectomy system in acute limb ischemia: the ReOpen registry
3. 15:10 - 15:15
  
  Visceral Artery Aneurysms (VAAs) – Management, surveillance and natural history analysis in a single UK centre over 10 years
4. 15:15 - 15:20
  
  Validation of new oszillometric PAOD parameters: Puls Wave Index (PWI), Tissue Optical Perfusion Pressure (TOPP) and oszillometric ABI vs. cw-Doppler-ABI
5. 15:20 - 15:25
  
  Single center experience for peripheral arterial interventions via percutaneous brachial artery access using a 4F sheath
6. 15:25 - 15:30
  
  Vascular complications after extracorporeal membrane oxygenation (ECMO)
7. 15:30 - 15:35
  
  Assessment of endovascular treatment for critical lower limb ischaemia in 321 consecutive patients
8. 15:35 - 15:40
  
  Routine screening coronary angiography examination and adequate coronary revascularisation is important for improvement of clinical outcomes of patients with critical limb ischemia
9. 15:40 - 15:45
  
  WIfI classification does not predict limb amputation risk in dialysis patients undergoing revascularisation for critical limb ischemia
10. 15:45 - 15:50
  
  Non-calcified steno-obstructive lesions of adbominal aorta are associated with worse results following endovascular treatment
11. 15:50 - 15:55
  
  New approach for the development and stratification of peripheral stents
12. 15:55 - 16:00
  
  Analysis of outcomes for bioresorbable vascular Scaffold use for the treatment of infra-popliteal disease
13. 16:00 - 16:05
  
  Early clinical results of the FLEX catheter in the treatment of below the knee lesions
14. 16:05 - 16:30
  
  Discussion and conclusion
16:30 - 18:00, Room 1 - Main Arena 1

Advanced solutions for calcified lesions and CTOs

Moderator:

Ramon Varcoe, Thomas Zeller

Panel:

Richard Heuser, Gunnar Tepe, Andrew Holden, Krishna Rocha-Singh, Darren Schneider, Arne Schwindt
1. 16:30 - 16:36
  
  Vessel preparation: What does it mean and what are the current tools (PTA, DA and scoring balloons)?
2. 16:36 - 16:41
  
  Impact of chronic total occlusion on outcomes: IN.PACT global CTO imaging cohort
3. 16:41 - 17:02
  
  Live case transmission from New York
4. 17:02 - 17:08
  
  Understanding the challenges with measuring calcium in DCB clinical trials
5. 17:08 - 17:14
  
  Vascular calcium: new pre-clinical models and new treatment solutions
6. 17:14 - 17:19
  
  Clinical experience with the Phoenix atherectomy system for complex calcified lesions
7. 17:19 - 17:25
  
  Applications of Lithoplasty for the treatment of calcified lesions
8. 17:25 - 17:30
  
  Shockwave Lithoplasty System treatment of calcified lesions: Intravascular OCT analysis
9. 17:30 - 17:50
  
  Live case transmission from Leipzig
10. 17:50 - 17:55
  
  The “Crack and Pave” technique for highly resistant calcified lesions: Initial results
11. 17:55 - 18:00
  
  Discussion and conclusion
16:30 - 18:00, Room 2 - Main Arena 2

SCRUB-IN WITH THE EXPERTS: Endovascular treatment of central venous stenosis of the chest

live from Zurich:

Nils Kucher

live from Galway:

Gerard O'Sullivan

Moderator:

Robert Lookstein, Stephen Black

Panel:

Ulf Teichgräber, Bart Dolmatch, Raghu Kolluri, Rick de Graaf
1. FLASH PRESENTATION: Drug-coated balloons for the treatment of symptomatic central venous stenosis
2. FLASH PRESENTATION: Interventional techniques for central venous stenosis of the chest
3. FLASH PRESENTATION: COVERA™ – First look at the AVeVA study update for treatment of venous anastomotic lesions in AV grafts and an update on the AVeNEW trial design for outflow stenosis in AV fistula circuits
16:30 - 18:00, Room 3 - Technical Forum

SCRUB-IN WITH THE EXPERTS: Carotid interventions

live from Leipzig:

Andrej Schmidt

live from Cotignola:

Fausto Castriota, Antonio Micari

Moderator:

Giancarlo Biamino, Gary Ansel

Panel:

Martin Storck, Carlo Setacci, Maria Antonella Ruffino
1. FLASH PRESENTATION: Current consideration for patient oriented revascularisation strategies: CAS vs. CEA vs. medical management
2. FLASH PRESENTATION: How to integrate latest technology to make carotid stenting safer
3. FLASH PRESENTATION: Latest clinical experience with integrated embolic protection during CAS and future directions
4. FLASH PRESENTATION: Combined carotid and coronary revascularisation: Is this a good idea?

Conference day 2

Wednesday, January 31st 2018

8:00 - 9:30, Room 1 - Main Arena 1

Below-the-knee revascularisation: Current status, challenges, and future outlook

Moderator:

Dierk Scheinert, Peter Schneider

Panel:

Jihad Mustapha, Steven Kum, Kazushi Urasawa, Osamu Iida
1. 08:00 - 08:05
  
  Comprehensive meta-analysis of endovascular versus bypass for critical limb ischemia – is bypass obsolete?
2. 08:05 - 08:10
  
  Three-year outcomes of surgical vs. endovascular revascularisation for critical limb ischemia: The Surgical reconstruction vs. Peripheral INtervention in pAtients with critical limb isCHemia (SPINACH) study
3. 08:10 - 08:17
  
  Retrograde tibial puncture has changed our algorithm for crossing tibial lesions in CLI: How and when to do it?
4. 08:17 - 08:24
  
  Advanced crossing and wiring techniques in BTK vessels
5. 08:24 - 08:51
  
  Live case transmission from Leipzig
6. 08:51 - 08:58
  
  Technical considerations for successful use of DCBs in BTK arteries: Lessons learned from preclinical studies
7. 08:58 - 09:03
  
  Update on the LUTONIX BTK Global Registry: First look at 300 patient interim follow up data
8. 09:03 - 09:10
  
  Patterns of vessel calcification in BTK arteries and implications for vessel preparation and atherectomy
9. 09:10 - 09:15
  
  Update on the Optimize BTK trial (Atherectomy with the CSI atherectomy catheter in combination with DCB in calcified BTK lesions)
10. 09:15 - 09:20
  
  Lithoplasty – also an option for calcified BTK vessels? Update on the Shockwave BTK study
11. 09:20 - 09:25
  
  Update on TOBA below-the-knee
12. 09:25 - 09:30
  
  Adventitial drug therapy below-the-knee: Update on LIMBO and TANGO
8:00 - 9:30, Room 2 - Main Arena 2

Endovascular repair for complex iliac aneurysms

Moderator:

Piergiorgio Cao, Armando Lobato

Panel:

Reza Ghotbi, Frank Vermassen, Reinhard Kopp, Daniela Branzan, Thomas Larzon, Olaf Richter
1. 08:00 - 08:06
  
  Iliac artery aneurysms – types and treatment
2. 08:06 - 08:12
  
  The long-term faith of EVAR in patients with ectatic iliac arteries
3. 08:12 - 08:18
  
  Clinical trial and real-world outcomes of an endovascular iliac aneurysm repair with the GORE® Iliac Branch Endoprosthesis (IBE)
4. 08:18 - 08:24
  
  Long-term results of IBD-EVAR: 10 year experience from Leipzig
5. 08:24 - 09:05
  
  Live from Paris: Treatment of an Iliac artery aneurysm with an iliac branched device – Step by step
6. 09:05 - 09:11
  
  The outcome of patients treated with bilateral iliac branched devices for CIA aneurysms
7. 09:11 - 09:17
  
  Is co-existing hypogastric aneurysm a contradiction for the treatment with iliac branched device? Insights from the European PELVIS registry, experience of 9 centers
8. 09:17 - 09:23
  
  A proposed treatment algorithm for iliac aneurysms
9. 09:23 - 09:30
  
  Discussion and conclusion
8:00 - 9:30, Room 3 - Technical Forum

Focus session: Embolisation therapies and interventional oncology – Part I

Moderator:

Ulf Teichgräber, Michael Moche

Panel:

Thomas J. Vogl, Peter Huppert, Robert Lookstein
1. 08:00 - 08:08
  
  Percutaneous tumor ablation: indications and technical innovations
2. 08:08 - 08:33
  
  Live case transmission from Frankfurt
3. 08:33 - 08:41
  
  Holmium-166 radioembolisation compared to Yttrium-90 radioembolisation
4. 08:41 - 08:49
  
  Radiofrequency ablation versus microwave ablation in HCC and liver metastasis
5. 08:49 - 09:14
  
  Live case transmission from Jena
6. 09:14 - 09:22
  
  Percutaneous after loading therapy in inoperable liver tumors
7. 09:22 - 09:30
  
  Radioembolisation in colorectal liver metastasis
8:00 - 9:30, Room 5 - Global Expert Exchange

Deep dive session: Lower limb interventions (part I) – Focus on vessel preparation and drug-coated balloons

Moderator:

Tony Das, Iris Baumgartner-Peuker

Panel:

George Adams, Hans Krankenberg
1. 08:00 - 08:15
  
  Live case transmission from Leipzig
2. 08:15 - 08:20
  
  What is vessel preparation and how have the DEFINITIVE LE and DEFINITVE AR results influenced current practice?
3. 08:20 - 08:25
  
  What have we learned so far in the REALITY study?
4. 08:25 - 08:30
  
  Laser in practice: defining the right settings across different lesion morphologies
5. 08:30 - 08:35
  
  The PRELUDE study: PRospective Study for the TrEatment of Atherosclerotic Lesions in the Superficial Femoral and/or Popliteal Arteries Using the Serranator® DevicE
6. 08:35 - 08:40
  
  Comparison of particulate embolisation in different DCB formulations
7. 08:40 - 08:45
  
  Real-world experience with a Paclitaxel Coated Balloon for the treatment of atherosclerotic infrainguinal arteries. Twelve-month results of the BIOLUX P-III All Comers Registry in diabetic patients
8. 08:45 - 08:50
  
  12-month results from the IN.PACT DCB in a Chinese population
9. 08:50 - 08:55
  
  12-month results with the ORCHID DCB: The Leipzig experience
10. 08:55 - 09:00
  
  The role of DCB in Korea practice: LUTONIX DCB Korean registry 1-year data in fem-popliteal arteries
11. 09:00 - 09:05
  
  First Report of the SELUTION Trial: 6-month 0utcomes of a Novel Sirolimus Coated DCB Technology Evaluated in SFA
12. 09:05 - 09:10
  
  The LEGDEB registry – 12-month results with the Legflow® DCB in femoropopliteal de novo and restenotic lesions
13. 09:10 - 09:15
  
  Impact of gender on outcomes: Review of the IN.PACT SFA 3-year results
14. 09:15 - 09:20
  
  Drug coated balloons vs. BMS for the treatment of femoropopliteal lesions
15. 09:20 - 09:25
  
  Health economic analysis of DCB use in Belgium: Implications for practice
16. 09:25 - 09:30
  
  Discussion and conclusion
8:00 - 18:00, Scientific Posters

Electronic posters will be displayed from 08:00 – 18:00 in front of Main Arena 1
9:00 - 10:45, Room 6 - Speakers' corner

Selected abstracts challenging cases – venous/AV

Moderator:

Jörn Balzer

Panel:

Bryan Yan
1. 09:00 - 09:05
  
  Management of 21 year old female with extensive bilateral phelgmasia cerulae dolens and ileocaval thrombosis
2. 09:05 - 09:10
  
  Ilio-Iliac arteriovenous fistula – a diagnostic and therapeutic challenge
3. 09:10 - 09:15
  
  Intracardiac migration of a stent implanted in the superior vena cava: Presentation of a severe complication after endovascular treatment of superior vena cava syndrome
4. 09:15 - 09:20
  
  Complexities in managing malignant pulmonary artery stenosis: difficult decisions in a patient with prior pneumonectomy
5. 09:20 - 09:25
  
  Endovascular repair of iliac vein laceration associated to complex pelvic fracture
6. 09:25 - 09:30
  
  Role of only balloon dilatation in treatment of postphelibitic patients with ilio-caval obstruction and good venous inflow
7. 09:30 - 09:35
  
  Recurrent non-malignant SVC in-stent restenosis treated with Culotte bifurcation stenting technique
8. 09:35 - 09:40
  
  Phlegmasia cerula dolens and compartmental syndrome as a complication of improperly managed femoro-popliteal DVT with May Thurner syndrome
9. 09:40 - 09:45
  
  Unusual approach to endovascular treatment of intractable iliofemoral deep venous thrombosis
10. 09:45 - 09:50
  
  Retrieval of embolised chemotherapy portacath in the heart by endovascular technique
11. 09:50 - 09:55
  
  Double barrel stent technique for treating chronic inferior vena cava occlusion
12. 09:55 - 10:00
  
  Combined open surgery and endovascular stenting for a case of long-standing iatrogenic femoral arteriovenous fistula complicated with pulmonary hypertension
13. 10:00 - 10:05
  
  Common iliac vein compression secondary to significant bladder distension
14. 10:05 - 10:10
  
  Endovascular avoidable complication in a lupus patient
15. 10:10 - 10:15
  
  Vascular access construction. A constant creative attitude is required
16. 10:15 - 10:20
  
  Radial access for fistula angioplasty: a minimally invasive and versatile option. Case report and literature review
17. 10:20 - 10:45
  
  Discussion and conclusion
9:00 - 10:30, Scientific Posters

Original research: PVD, SFA, femoral

Juror:

John Laird, Lawrence Garcia
1. 09:00 - 09:05
  
  The effect of supervised exercise on biomarker levels in individuals with peripheral arterial disease – a systematic review
2. 09:05 - 09:10
  
  Day-Case Treatment of PAD: Single-tertiary center experience
3. 09:10 - 09:15
  
  Improving balloon angioplasty: Lessons learned from the DCB and stent trials
4. 09:15 - 09:20
  
  Incidence and predictors of access site pseudoaneurysm in peripheral arterial disease therapeutic angioplasty
5. 09:20 - 09:25
  
  Preliminary results of the Italian multicentre registry using a dual component vascular stent for the treatment of distal SFA with or without involvement of popliteal artery
6. 09:25 - 09:30
  
  Comparison of endovascular recanalisation vs. open bypass surgery for infra-inguinal Trans-Atlantic Inter-Society Consensus (TASC) – D arterial lesions – a retrospective comparative study
7. 09:30 - 09:35
  
  Diagnostic and surgical experience with Popliteal Artery Entrapment Syndrome PAES in one single clinical center
8. 09:35 - 09:40
  
  Post-dilatation of an interwoven nitinol stent using a paclitaxel-eluting balloon for revascularisation of complex femoro-popliteal lesions
9. 09:40 - 09:45
  
  Predictors of severe dissection after plain balloon angioplasty for superficial femoral artery disease
10. 09:45 - 09:50
  
  Outcomes of endovascular treatment for TASC-II D femoropopliteal occclusive disease
11. 09:50 - 09:55
  
  Successful endovascular treatment with the phoenix atherectomy system in patients with chronic limb ischemia. A mini-series of thirteen consecutive patients.
12. 09:55 - 10:00
  
  Risk factors for restenosis after drug-coated balloon angioplasty for complex femoropopliteal artery diseases
13. 10:00 - 10:05
  
  Endovascular management of femoropopliteal TASCII C and D lesions
14. 10:05 - 10:10
  
  Drug eluting balloon angioplasty versus bare metal stenting in treating femoro-popliteal occlusive disease
15. 10:10 - 10:15
  
  Clinical outcomes and risk factor analysis of restenosis after endovascular treatment of femoro-popliteal lesions using atherectomy device
16. 10:15 - 10:20
  
  Comparative biomechanics and vascular healing response of 3 contemporary stents in balloon-predilated femoral arteries of familial hypercholesterolemic swine
17. 10:20 - 10:25
  
  Stent expansion in superficial femoral artery will improve as round shape after long term period even in the case of eccentric plaque distribution – IVUS confirmation
18. 10:25 - 10:30
  
  Experience of endovascular techniques in treatment of long supberficial femoral artery occlusions
9:30 - 11:00, Room 1 - Main Arena 1

Symposium: DCB progress update: science, evidence, and vessel prep algorithms

supported with an educational grant from Spectranetics, a Philips Company

Moderator:

Gunnar Tepe, Sean Lyden

Panel:

Ehrin Armstrong, Simon Bays
1. 09:30 - 09:33
  
  Introduction
2. 09:33 - 09:40
  
  Requirements and specificities of a low-dose DCB: the Stellarex case example
3. 09:40 - 09:47
  
  Stellarex level 1 evidence in common to complex patients
4. 09:47 - 10:07
  
  Live case transmission from Leipzig
5. 10:07 - 10:14
  
  As simple as scoring: Angiosculpt vessel prep and case review
6. 10:14 - 10:21
  
  In-stent-restenosis: new evidence from laser + DCB
7. 10:21 - 10:41
  
  Live case transmission from Leipzig
8. 10:41 - 11:00
  
  Discussion and conclusion
9:30 - 11:00, Room 2 - Main Arena 2

EVAR – Current status, open questions, and future perspectives

Moderator:

Frank Veith, Frans Moll

Panel:

Sven Seifert, Jean-Pierre Becquemin, Martin Malina, Wei Guo, Roger Greenhalgh, Giovanni Torsello
1. 09:30 - 09:36
  
  Steps to clinical effectiveness and cost effectiveness – Lessons from EVAR 1
2. 09:36 - 09:42
  
  Endovascular repair for patients physically unsuitable for open repair. EVAR 2 15-year results
3. 09:42 - 09:48
  
  RCTs for EVAR: 15 years later are the conclusions obsolete?
4. 09:48 - 09:54
  
  How much open surgery is still required in aortic surgery: A review of 800 aortic aneurysm cases
5. 09:54 - 10:00
  
  Complex-anatomy large aneurysms and why we should consider use of no-treatment and open-surgery strategies more frequently
6. 10:00 - 10:05
  
  Role of gender in TEVAR and EVAR: report from the GREAT registry
7. 10:05 - 10:10
  
  Long-term outcomes of EVAR in female patients: A 5-year analysis from the ENGAGE registry
8. 10:10 - 10:40
  
  Live case transmission from Leipzig
9. 10:40 - 10:45
  
  Ovation endograft: 4-year, real world results from the Ovation European post market registry
10. 10:45 - 10:50
  
  10-year outcome analysis of the ITER registry with the GORE Excluder® endograft for infrarenal abdominal aortic aneurysms
11. 10:50 - 10:55
  
  Predictors of abdominal aortic aneurysm sac enlargment after EVAR; long-term results from the ENGAGE registry
12. 10:55 - 11:00
  
  Discussion
9:30 - 10:15, Room 3 - Technical Forum

SYMPOSIUM: Embolisation and mechanical thrombectomy

supported with an educational grant from Penumbra

Moderator:

Jos van den Berg

Panel:

Lorenzo Paolo Moramarco, Gianmarco de Donato, Stephen D'Souza
1. 09:30 - 09:34
  
  Introduction
2. 09:34 - 09:46
  
  Efficient endoleak treatment with Penumbra large volume coils
3. 09:46 - 09:58
  
  Is the Indigo system a surgeon’s best friend? My experience
4. 09:58 - 10:10
  
  Indigo system: can mechanical thrombectomy be a cost effective solution?
5. 10:10 - 10:15
  
  Discussion and conclusion
9:30 - 10:30, Room 4 - Discussion Forum

SITE@LINC: An open debate about new concepts and concerns in EVAR/TEVAR Objective: to identify current limitations and propose future directions

Moderator:

Vicente Riambau

Discussant:

Eric Verhoeven, Dittmar Böckler, Andrew Holden, Eric Ducasse
1. TOPICS TO BE DISCUSSED: How do you foresee the real role of the sac-filling concept?
2. TOPICS TO BE DISCUSSED: The post-implant syndrome: is it a real concern to be avoided?
3. TOPICS TO BE DISCUSSED: What will be the best endovascular solution for the arch pathology?
4. TOPICS TO BE DISCUSSEN: Are new adjuvants needed for acute and chronic Type B dissection management
9:30 - 10:45, Room 5 - Global Expert Exchange

JET@LINC

Moderator:

Giancarlo Biamino, Yoshiaki Yokoi, Hiroyoshi Yokoi

Panel:

Kazushi Urasawa, Osamu Iida
1. 09:30 - 09:35
  
  Introduction
2. 09:35 - 09:43
  
  Aorto-Iliac artery disease treated with endovascular therapy (EVT) of stent placement; multicenter prospective registry in Japan: OMOTENASHI
3. 09:43 - 09:51
  
  Peripheral artery CTO crossing in Japan
4. 09:51 - 09:59
  
  Challenges for calcified complex SFA lesion assessed by intravascular ultrasound
5. 09:59 - 10:07
  
  Ideal strategy for long SFA-CTO according to pathological findings
6. 10:07 - 10:15
  
  Optimal endpoint of BTK intervention for wound healing
7. 10:15 - 10:23
  
  Decision making of treatment strategy in patients with CLI, learn from Priority and SPINACH study
8. 10:23 - 10:45
  
  Discussion and conclusion
10:15 - 11:00, Room 3 - Technical Forum

SYMPOSIUM: Advances in peripheral embolisation therapies

supported with an educational grant from Medtronic

Moderator:

Marcus Treitl

Panel:

Nuno Dias, Hans Lindgren
1. 10:15 - 10:20
  
  Introduction
2. 10:20 - 10:30
  
  Miniaturisation of plugs: How does it advance the embolisation practice? Lecture and case series.
3. 10:30 - 10:40
  
  Advances in coil design: the new 3D detachable fibered coil
4. 10:40 - 10:50
  
  Embolisation of Type II endoleaks with a combination of liquid embolic and microvascular plug
5. 10:50 - 11:00
  
  Discussion and conclusion
10:45 - 12:30, Room 5 - Global Expert Exchange

Deep dive session: Lower limb interventions (part II) – Focus on Combination therapies and new implants

Moderator:

Giancarlo Biamino, Krishna Rocha-Singh

Panel:

Hiroyoshi Yokoi
1. 10:45 - 10:50
  
  Clinical plasticity of PLLA – Novel BioResorbable vascular platforms from India
2. 10:50 - 10:55
  
  FIRST TIME DATA RELEASE: Outcomes at 2 years in stented vs. non-stented patients post-DCB: A subanalysis from the IN.PACT Global study
3. 10:55 - 11:00
  
  FIRST TIME DATA RELEASE: Real PTX RCT: 3 year data from a randomized comparison of DCB vs. DES in femoropopliteal lesions
4. 11:00 - 11:30
  
  Live case transmission from Leipzig
5. 11:30 - 11:35
  
  Directional Atherectomy and Anti-Restenotic Therapy (DAART) in multilevel disease
6. 11:35 - 11:40
  
  Combination therapy with atherectomy followed by DCB: 1-year outcomes with Lutonix DCB and 1-year outcomes with IN.PACT DCB
7. 11:40 - 11:45
  
  12-month and preliminary 24-month outcomes of combining a DCB with a modern generation of nitinol stent in femoropopliteal lesions: analysis of the BIOLUX 4 EVER study
8. 11:45 - 11:50
  
  Short-term results of the RAPID Randomised trial of the Legflow® paclitaxel-eluting balloon with supera stenting vs. supera stenting alone for the treatment of intermediate and long superficial femoral artery lesions
9. 11:50 - 11:55
  
  Combination of Supera DCB in revascularisation of long femoropopliteal occlusions. Single center experience
10. 11:55 - 12:00
  
  12-month outcomes in the EVOLUTION study: Investigating the iVolution stent in femoropopliteal lesions
11. 12:00 - 12:05
  
  Impact of Zilver PTX after stent implantation for femoropopliteal lesions for 2-year follow up. How to maximize performance of Zilver PTX
12. 12:05 - 12:10
  
  The clinical comparison of Zilver PTX and Innova for femoropopliteal lesions in Japanese single center
13. 12:10 - 12:15
  
  The Supera stent in retrograde vascular access for SFA ostium treatment: The SUPRA-FAST registry
14. 12:15 - 12:20
  
  Laser and DCB for SFA ISR: follow-up of a single center cohort up to 5 years
15. 12:20 - 12:25
  
  LIBERTY 360: Predictors of 1-year outcomes of endovascular device interventions in patients with symptomatic lower extremity peripheral artery disease
16. 12:25 - 12:30
  
  Discussion and conclusion
11:00 - 12:30, Room 1 - Main Arena 1

Symposium: Extended indication for the new GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis

supported with an educational grant from Gore & Associates

Moderator:

Mauro Gargiulo

Panel:

Giovanni Torsello, Michele Antonello, Chris Metzger, Michel Reijnen
1. 11:00 - 11:05
  
  Introduction by chairman
2. 11:05 - 11:15
  
  Complexity of iliac occlusive disease, current treatment algorithm, and treatment gaps
3. 11:15 - 11:25
  
  2-year outcomes from the GORE. VIABAHN. VBX Balloon Expandable IDE study
4. 11:25 - 11:40
  
  Recorded case presentation from Arnhem (NL)
5. 11:40 - 11:50
  
  Aortic challenges, quantitative analysis in fenestrated procedures
6. 11:50 - 12:05
  
  Recorded case presentation from Münster
7. 12:05 - 12:30
  
  Discussion and conclusion by chairman
11:00 - 12:30, Room 2 - Main Arena 2

Advanced techniques for juxtarenal aneurysms and challenging neck anatomy

Moderator:

Eric Verhoeven, Jean-Pierre Becquemin

Panel:

Konstantinos Donas, Piotr Kasprzak, Eric Ducasse, Spiridon Botsios
1. 11:00 - 11:06
  
  A new conformable abdominal endovascular device
2. 11:06 - 11:12
  
  Early experience with Ovation Alto™ stent graft: next generation ovation design with an elevated sealing ring
3. 11:12 - 11:18
  
  Custom EVAR (c-EVAR) designs, a step in between standard EVAR and FEVAR devices
4. 11:18 - 11:24
  
  Endovascular fixation of aortic endografts – a solution for short aortic necks?
5. FEVAR VS. CH-EVAR: WHAT IS THE BEST FOR CHALLENGING AORTIC NECKS?
6. 11:24 - 11:30
  
  In favor of Ch-EVAR and Endoanchor-EVAR and how they have emerged as highly useful treatment options for short-neck and juxtarenal AAAs
7. 11:30 - 11:35
  
  In favor of FEVAR and why extended sealing zones with 3 and 4 fenestrations are better than standard double fenestration
8. 11:35 - 12:03
  
  Live from Münster: Chimney EVAR for short aortic neck pathology – Step by step
9. 12:03 - 12:09
  
  Two year comparison of fenestrated and branch grafts vs. parallel grafts for the treatment of juxtarenal and thoracoabdominal aneurysms at a single center
10. 12:09 - 12:15
  
  Evaluating the optimal combination of aortic endografts and chimney devices in the treatment of complex aneuysms: insights from the Pericles registry
11. 12:15 - 12:21
  
  First clinical experience with a new balloon-expandable stent graft: Potential advantages for side branch reconstruction during EVAR of complex pathologies
12. 12:21 - 12:27
  
  ChEVAS Nellix with chimneys: What we've learned from a single center study
13. 12:27 - 12:30
  
  Discussion and conclusion
11:00 - 12:30, Room 3 - Technical Forum

Focus session: Embolisation therapies and interventional oncology – Part II

Moderator:

Robert Lookstein, Thomas J. Vogl

Panel:

Ralf-Thorsten Hoffmann, Ulf Teichgräber, Boris Radeleff
1. 11:00 - 11:08
  
  Efficacy and safety of chemoembolisation using 40µm Doxorubicin-eluting microshperes in hepatocellular carcinoma
2. 11:08 - 11:33
  
  Live case transmission from Jena
3. 11:33 - 11:41
  
  Chemoembolisation with drug eluting beads preloaded with irinotecan (DEBIRI) liver metastases
4. 11:41 - 11:49
  
  Chemoembolisation using Lipiodol based techinques
5. 11:49 - 12:14
  
  Live case transmission from Frankfurt
6. 12:14 - 12:22
  
  Immuno oncology in regional treatments of metastasis
7. 12:22 - 12:30
  
  Do we need an Angio-CT suite to optimize embolisation procedures?
11:00 - 12:00, Room 4 - Discussion Forum

VIVA@LINC: Strategies on the frontline – The year in review: My worst complication of 2017

Moderator:

Peter Schneider

Discussant:

Ehrin Armstrong, Gary Ansel
1. Aortic
2. Carotid
3. Lower extremity
4. Venous
5. This is a case-based session focusing on what we like best ... real cases with challenges and complications that make the experts sweat. In this amphitheater setting, audience participation is encouraged and step-by-step case management is featured and discussed. This round room setting is dedicated to controversial or interactive talk-show-like sessions.
11:00 - 12:30, Room 6 - Speakers' corner

Patient centered clinical trials: Engagement and innovation

Moderator:

Marc van Sambeek
1. 11:00 - 11:05
  
  Introduction
2. 11:05 - 11:15
  
  Patient recruitment and retention challenges
3. 11:15 - 11:25
  
  The role of patient reported outcomes in cardiovascular trials
4. 11:25 - 11:35
  
  Incorporating the “patient's voice” in clinical research
5. 11:35 - 11:45
  
  Digital patient engagement/ patient centric technologies
6. 11:45 - 11:55
  
  EU-MDR/ GDPR: From complex regulation to impactful change
7. 11:55 - 12:00
  
  Discussion and conclusion
11:00 - 12:30, Room 7 - Speakers' corner

Selected abstracts original research – AV/venous

Moderator:

Klaus Mathias, Steven Kum
1. 11:00 - 11:05
  
  A prospective, multi-center, randomised controlled trial evaluating the safety and efficacy of the paclitaxel releasing peripheral balloon dilatation catheter (APERTO OTW) for the treatment of arteriovenous fistulae stenosis in patients undergoing hemodialysis
2. 11:05 - 11:10
  
  Aspiration thrombectomy of dialysis fistulas thrombosis
3. 11:10 - 11:15
  
  Balloon angioplasty with selective stenting strategy in treatment of hemodialysis related central vein occlusive lesions
4. 11:15 - 11:20
  
  Focal force balloon plus drug eluting balloon new strategy for vascular access stenosis
5. 11:20 - 11:25
  
  Outcomes comparison of chest wall arteriovenous grafts and lower extremity arteriovenous grafts in patients with long-standing renal failure
6. 11:25 - 11:30
  
  Current trend in West of Ireland for initiating dialysis in chronic renal failure patients
7. 11:30 - 11:35
  
  Catheter-directed fragmentation with local thrombolytic therapy and anticoagulant therapy in patients with intermediate-high-risk pulmonary embolism
8. 11:35 - 11:40
  
  Mid-term results of catheter-directed foam sclerotherapy combined with tumescent local anesthesia for treatment of great saphenous vein incompetence
9. 11:40 - 11:45
  
  The v-block occlusion stent for varicose vein treatment
10. 11:45 - 11:50
  
  Compression therapy and endovenous treatment of Klippel-Trenaunay syndrome
11. 11:50 - 11:55
  
  Therapy of varicose veins in patients with severe comorbidities
12. 11:55 - 12:00
  
  Risk of venous stenting across the inguinal ligament on occlusion of great saphenous vein
13. 12:00 - 12:05
  
  Histological changes following closure FAST treatment
14. 12:05 - 12:10
  
  Acute upper extremity deep vein thrombosis-effectiveness of SVC filter
15. 12:10 - 12:15
  
  Role of inferior vena cava filter insertion prior to thrombolysis of acute ilio femoral deep venous thrombosis
16. 12:15 - 12:30
  
  Discussion and conclusion
11:00 - 12:35, Scientific Posters

Original research: BTK, CLI, PVD

Juror:

Roberto Ferraresi, Ramon Varcoe
1. 11:00 - 11:05
  
  Evaluation of the role of below-the-knee-revascularization (BTKR) for the treatment of peripheral arterial occlusive disease (PVD) in stage III and IV according to the Fontaine classification
2. 11:05 - 11:10
  
  Below knee angioplasty in diabetic patients: predictors of major adverse clinical outcomes
3. 11:10 - 11:15
  
  Prevalence of critical limb ischemia and peripheral arterial disease in patients with end-stage renal disease on hemodialysis due to diabetic nephropathy, from PREDICT study
4. 11:15 - 11:20
  
  New method for assessment the efficiency of revascularization in patients with critical limb ischaemia
5. 11:20 - 11:25
  
  Impact of myocardial injury after percutaneous transluminal angioplasty (PTA) in patients with critical lower limbs ischemia (CLI) on major adverse cardiovascular events
6. 11:25 - 11:30
  
  Infra-popliteal interventions with drug eluting balloons vs. regular balloons in critical limb ischaemia – single center real world experience
7. 11:30 - 11:35
  
  Initial experience using closed incision management with negative pressure therapy after lower limb amputation in vascular patients: our case series
8. 11:35 - 11:40
  
  Covered stent to treat iatrogenic femoral pseudoaneurysm
9. 11:40 - 11:45
  
  Comparison between full vs. partial revascularisation during endovascular management of multilevel lower limb arterial disease in
10. 11:45 - 11:50
  
  AngioSeal for puncture site closure after antegrade procedures in peripheral arterial disease patients
11. 11:50 - 11:55
  
  Catheter directed thrombolysis in management of early acute thrombotic ischemia
12. 11:55 - 12:00
  
  Study on the application of relay puncture technique in the treatment of patients with complicated arteriosclerosis obliterans
13. 12:00 - 12:05
  
  13 years experience of peripheral arterial disease intervention in tertiary referral center
14. 12:05 - 12:10
  
  Preclinical results of a novel zinc alloy as a platform for bioresorbable vascular scaffolds in peripheral arterial disease
15. 12:10 - 12:15
  
  TOPP-ABI – Tissue Optical Perfusion Pressure-Ankle Brachial Index: New parameters for diagnosis of PAOD and interventional results
16. 12:15 - 12:20
  
  Potentiality of sheathless naked stent delivery technique on the puncture complications in patients with peripheral artery disease
17. 12:20 - 12:25
  
  TrackCath system new approach to cannulation
18. 12:25 - 12:30
  
  Use of leukotrienes and thromboxanes as new prognostic biomarker of recurring restenosis after endovascular treatment in patients with lower limb ischemia
19. 12:30 - 12:35
  
  Clinical outcome of managing to lower low density lipoprotein cholesterol levels to peripheral arterial disease from I-PAD study
12:30 - 13:30, Room 1 - Main Arena 1

Lunch
12:30 - 13:30, Room 2 - Main Arena 2

LUNCH SYMPOSIUM: Advancing EVAR: Access more AAA patients and customise each seal

supported with an educational grant from Endologix

Moderator:

Andrew Holden

Panel:

Eric Verhoeven, Sean Lyden, Martin Storck
1. 12:30 - 12:40
  
  Impact of infrarenal neck diameter on midterm outcome following EVAR: Considerations for repair choice and surveillance
2. 12:40 - 12:50
  
  Finally, an ultra-low profile endograft that is not a tradeoff: Deliverability, patency, and durability of the Ovation® platform
3. 12:50 - 13:00
  
  Why Ovation® may improve EVAR outcomes in women
4. 13:00 - 13:25
  
  Recorded case presentation
5. 13:25 - 13:30
  
  Discussion and conclusion
12:30 - 13:30, Room 5 - Global Expert Exchange

LUNCH SYMPOSIUM: New options and treatment times with EKOS™ Acoustic Pulse Thrombolysis™

supported with an educational grant from BTG

Moderator:

Nils Kucher

Panel:

Mark J. Garcia, Keith M. Sterling, Nima Hatam
1. 12:30 - 12:35
  
  Introduction
2. 12:35 - 12:50
  
  Access PTS – How do I treat my PTS patients?
3. 12:50 - 13:05
  
  The OPTALYSE PE Trial – Reducing thrombolytic dose and treatment times with EKOS™ in the treatment of pulmonary embolism patients
4. 13:05 - 13:20
  
  The surgeon's perspective on PE
5. 13:20 - 13:30
  
  Discussion and conclusion
12:30 - 14:00, Room 6 - Speakers' corner

Innovation forum – PVD/ carotid/ venous/ embolisation/ miscellaneous

Moderator:

Jos van den Berg

Panel:

Stanislaw Bartus, Jörn Balzer
1. 12:30 - 12:36
  
  The development of the Neuroguard IEP system: A novel 3-in-1 carotid artery stent system with an integrated embolic protection filter and post-dilation balloon
2. 12:36 - 12:42
  
  Histological evaluation of filter contents in mesh-covered vs standard nitinol stents during carotid stenting using the paladin system
3. 12:42 - 12:48
  
  The effect of carotid stent flushing during carotid artery stenting on the delayed embolic events
4. 12:48 - 12:54
  
  Percutaneous arteriovenous fistula creation with the Ellipsys Vascular Access system – Initial results from the first centre in Europe
5. 12:54 - 13:00
  
  GPX by Fluidx medical technology: a biomimetic, in situ setting embolisation agent
6. 13:00 - 13:06
  
  Perfused Human Thiel embalmed cadavers – liquid embolisation training model
7. 13:06 - 13:12
  
  GELITA-SPON® RAPID3 and TUFT-IT ® in different open vascular procedures
8. 13:12 - 13:18
  
  Initial experience of SIOXX XL stent use in occlusive venous disease
9. 13:18 - 13:24
  
  Peripheral venous flow model for device testing and training in human Thiel embalmed cadavers
10. 13:24 - 13:30
  
  Double antegrade femoral sheath for kissing technique in infrapopliteal tibial angioplasty
11. 13:30 - 13:36
  
  Percutaneous deep venous foot arterialisation – a new technique for creating arterial-venous fistula
12. 13:36 - 13:42
  
  Imaging analysis of angioscopy using open source computer vision library in patients with BTK amputation and salvaged limb
13. 13:42 - 14:00
  
  Discussion
12:35 - 13:20, Room 3 - Technical Forum

Lunch symposium: Is there a need for flexible stents in patients with venous outflow obstruction?

supported with an educational grant from COOK Medical

Moderator:

Stephen Black

Panel:

Marta Ramírez Ortega, Rick de Graaf
1. 12:35 - 12:40
  
  Introduction
2. 12:40 - 12:55
  
  Helping patients with venous outflow obstruction get back to living in Madrid
3. 12:55 - 13:10
  
  Post thrombotic syndrome: the importance of stent flexibility
4. 13:10 - 13:20
  
  Discussion and conclusion
12:35 - 13:20, Room 4 - Discussion Forum

Lunch symposium: Drug-coated balloons for peripheral interventions: a 360° virtual reality experience

supported with an educational grant from Cardionovum

Moderator:

Peter Goverde, Dierk Scheinert
1. 12:35 - 12:38
  
  Introduction
2. 12:38 - 12:45
  
  SAFEPAX®: What’s new in the 3rd generation paclitaxel balloon matrix coating?
3. 12:45 - 12:55
  
  How can we improve treatment of long femoropopliteal lesions with DCB?
4. 12:55 - 13:05
  
  Recorded case presentation: let’s do it together: experience the future of “medicine in virtual reality”
5. 13:05 - 13:15
  
  Recorded case presentation: how can we protect the (CLI) patients to the potential risk of microembolisation?
6. 13:15 - 13:20
  
  Conclusions and closing remarks
13:00 - 14:25, Scientific Posters

Challenging cases: BTK, CLI, PVD, SFA

Juror:

Marianne Brodmann, Iris Baumgartner-Peuker
1. 13:00 - 13:05
  
  Rescue procedure with mechanical thromboaspiration in a case of acute embolism into dorsalis pedis artery during percutaneous revascularization of superficial femoral artery obstruction
2. 13:05 - 13:10
  
  Endovascular treatment in combine aortoiliac occlusive disease TASC D and infrainguinal lesion TASC D in CLI patient
3. 13:10 - 13:15
  
  Complete healing of advanced diabetic foot ulcers by percutaneous transluminal angioplasty
4. 13:15 - 13:20
  
  Recanalisation of a chronic total occlusion in a popliteal artery using a FLEX® scoring catheter prior to drug coated balloon
5. 13:20 - 13:25
  
  Cost effectiveness of carbon dioxide as contrast medium to guide endovascular treatment of chronic lower limb ischemic patients with impaired renal function
6. 13:25 - 13:30
  
  Aortic rupture following catheter directed thrombolysis
7. 13:30 - 13:35
  
  Iatrogenic internal mammary artery pseudoaneurysm treated with ultrasound guided percutaneous thrombin injection
8. 13:35 - 13:40
  
  Minimally invasive EVT for CIA/EIA/SFA-CTO using the IVUS preceding technique in the popliteal artery approach
9. 13:40 - 13:45
  
  Safety and efficacy of hybrid therapy for subacute and chronic peripheral artery occlusions
10. 13:45 - 13:50
  
  Role of endovascular management in treatment of surgical high risk patients with popliteal artery aneurysm
11. 13:50 - 13:55
  
  Successfully endovascular treated femoral artery following reocclusion of inserted venous vascular bridge after septic arrosional bleeding after xenogenic patch plastic
12. 13:55 - 14:00
  
  Recanalisation total occlusion SFA thru tibial artery
13. 14:00 - 14:05
  
  Combined stenting and drug-coated balloon for complex femoropopliteal disease
14. 14:05 - 14:10
  
  A case of delayed pseudo-aneurysm after stent thrombosis of superficial femoral artery stenting
15. 14:10 - 14:15
  
  IVUS can tell the risk of vessel rupture even if SFA intervention
16. 14:15 - 14:20
  
  Endovascular management with catheter directed thrombolysis for treatment of chronic occluded femoro-popliteal bypass
17. 14:20 - 14:25
  
  Early occlusion of two cases after treatment of peripheral artery aneurysms with multilayer flow modulator stents: lessens to be learned
13:30 - 15:00, Room 1 - Main Arena 1

Symposium: Lutonix® Drug Coated Balloon – Evidence in SFA, BTK, and AV

supported with an educational grant from C. R. BARD

Moderator:

Dierk Scheinert

Panel:

Aloke Finn, Scott Trerotola, Luis Mariano Palena, Kate Steiner, Martin Banyai
1. 13:30 - 13:35
  
  Introduction
2. 13:35 - 13:45
  
  Are all DCBs the same?
3. 13:45 - 13:55
  
  Treatment of TASC C & D lesions with DCB
4. 13:55 - 14:05
  
  Is DCB treatment right for below-the-knee patients?
5. 14:05 - 14:15
  
  Management of recurring infrapopliteal disease in diabetic patients with critical limb ischemia – a single center experience
6. 14:15 - 14:25
  
  Long term benefit effects of Lutonix 035 DCB
7. 14:25 - 14:35
  
  The role of Lutonix DCB in AV fistula dysfunction management in our practice
8. 14:35 - 14:45
  
  DCB outcomes in real world patients with restenotic AV fistula
9. 14:45 - 15:00
  
  Live case transmission from Leipzig
13:30 - 15:00, Room 2 - Main Arena 2

Acute aortic syndrome: Intramural hematoma, penetrating ulcer, and aortic dissection

Moderator:

Marc van Sambeek, Wei Guo

Panel:

Weiguo Fu, Tilo Kölbel, Wolfgang Ritter
1. 13:30 - 13:36
  
  Intramural hematoma and penetrating ulcers: Natural history and indications for treatment
2. 13:36 - 13:42
  
  Optimal medical treatment for patients with TBADs: Where does it usually go wrong
3. 13:42 - 13:48
  
  Technical considerations for EVAR of Type B aortic dissections
4. 13:48 - 13:54
  
  Despite common believe – oversizing is also justified in TEVAR for Type B aortic dissections
5. 13:54 - 14:20
  
  Live case transmission from Paris
6. 14:20 - 14:26
  
  Asymptomatic collapse of the true lumen in TBAD or “radiologic malperfusion”: Can TEVAR intervention be justified with available evidence?
7. 14:26 - 14:32
  
  Predicting successful aortic remodeling and clinical success of EVAR in Type B aortic dissections – What can we learn from pre-op CT imaging?
8. 14:32 - 14:42
  
  Branched EVAR for a chronic Type B dissection through the false lumen
9. 14:42 - 14:48
  
  First line treatment of acute Type B dissections with the MFM multilayer stent: Preservation of branches and remodelling of the aorta – Does it work?
10. 14:48 - 14:54
  
  Secondary procedures after EVAR for Type B aortic dissections – When and how?
11. 14:54 - 15:00
  
  Adjunctive techniques to induce false lumen thrombosis after TEVAR for TBADs
13:30 - 15:00, Room 3 - Technical Forum

VIVA@LINC: Deep dive into vessel prep: Is it a fad or the optimal pathway forward?

Moderator:

Gary Ansel, Krishna Rocha-Singh

Panel:

Ehrin Armstrong, Tony Das, John Laird, Peter Schneider

live from Teaneck:

John Rundback
1. FLASH PRESENTATION: What can coronary specialists teach the vascular community about the value of vessel prep?
2. FLASH PRESENTATION: Defining vessel prep: how can we set ourselves up for best results?
3. FLASH PRESENTATION: Atherectomy: is vessel preparation for DCB the breakthrough indication?
4. FLASH PRESENTATION: Future algorithm for lower extremity revascularisation: where does vessel prep fit?
13:30 - 14:15, Room 5 - Global Expert Exchange

Expert opinion on deep venous stenting – patient selection, technique, and clinical outcomes

supported with an educational grant from Boston Scientific

Moderator:

Stephen Black

Panel:

Michael Lichtenberg, Olivier Hartung
1. 13:30 - 13:35
  
  Introduction
2. 13:35 - 13:45
  
  Venous stenting experience in Arnsberg
3. 13:45 - 13:55
  
  Venous stenting experience in Modena – video presentation
4. 13:55 - 14:05
  
  Venous stenting experience in Marseille
5. 14:05 - 14:15
  
  Discussion and conclusion
13:30 - 14:30, Room 7 - Speakers' corner

Selected abstracts original research – SFA/femoral

Moderator:

Ralf Langhoff

Panel:

Ulrich Speck, George Adams
1. 13:30 - 13:35
  
  Safety and efficacy of distal superficial femoral artery puncture for femoropopliteal occlusive lesions; result from the multicenter REVERSide registry
2. 13:35 - 13:40
  
  Rotational thrombectomy (Rotarex©) for (sub)acute limb ischemia– a safe approach also in patients with diabetes mellitus?
3. 13:40 - 13:45
  
  The randomised Freeway stent study completed the 12-month follow up and favors the use of drug-eluting balloons over plain balloons for the postdilatation of nitinol stents in the SFA and PI segment to lower restenosis rate
4. 13:45 - 13:50
  
  The use of a Colapinto TIPS needle under cone-beam CT guidance for true lumen re-entry in subintimal recanalization of chronic iliac artery occlusion
5. 13:50 - 13:55
  
  A pilot study of femoropopliteal artery revascularisation with Orchid DCB: Short-term results from a single center
6. 13:55 - 14:00
  
  Drug-coated balloons: Impact of the balloon structure on drug transfer
7. 14:00 - 14:05
  
  Comparison of primary long stenting versus primary short stenting for long femoropopliteal artery disease (PARADE): A randomised controlled multicenter trial
8. 14:05 - 14:10
  
  Distal hybrids – an option in long SFA CTO accompanied by severely compromized crural runoff
9. 14:10 - 14:15
  
  Endovascular revascularisation of native femoropopliteal arteries after bypass graft failure for limb salvage
10. 14:15 - 14:20
  
  Difference of tissue characters of early and late femoropopliteal in-stent restenosis evaluated by high resolution intravascular imaging, optical coherence tomography
11. 14:20 - 14:25
  
  Treatment of femoropopliteal atherosclerotic lesions using the Ranger paclitaxel-coated balloon catheter – 12-month results from an all-comers registry
12. 14:25 - 14:30
  
  Discussion and conclusion
14:00 - 15:00, Room 4 - Discussion Forum

Experience the treatment journey of complex cases with innovative vascular solution – Case studies across the spectrum of vascular care

supported with an educational grant from Gore & Associates

Moderator:

Michel Makaroun
1. Treatment of complex thoracic cases
2. Clinical implications of the aortic arch and thoracic curvature remodeling after TEVAR
3. Preserving the hypogastric artery: why, when, and how
14:00 - 15:30, Room 6 - Speakers' corner

Selected abstracts challenging cases – EVAR

Moderator:

Piergiorgio Cao

Panel:

Daniela Branzan
1. 14:00 - 14:05
  
  TEVAR to false lumen of chronic Type B aortic dissection with aneurysmal dilatation when there are no other options, novel technique
2. 14:05 - 14:10
  
  Management of abdominal compartment syndrome after rupture EVAR in 75 year IHD patient
3. 14:10 - 14:15
  
  Descending thoracic aneurysm complicating subacute aortic dissection with significant right common iliac secondary tear and static malperfusion of right kidney intended 2 stage procedure, unexpected outcome
4. 14:15 - 14:20
  
  9 cm abdominal aortic aneurysm with angulated neck – an endovascular challenge: case report
5. 14:20 - 14:25
  
  Management of a symptomatic mycotic celiac artery aneurysm with chimney technique
6. 14:25 - 14:30
  
  Acute lower limbs ischemia as a late complication after EVAR
7. 14:30 - 14:35
  
  Hybrid bail-out carotid chimney and concurrent intracranial thrombolysis for acute stoke 7 days post TEVAR
8. 14:35 - 14:40
  
  Treatment of complex dissecting aortic aneurysm: targeting the fenestrations. Case report
9. 14:40 - 14:45
  
  Visceral debranching and periscope technique combined with endovascular repair for the treatment of thoracoabdominal aortic aneurysm
10. 14:45 - 14:50
  
  Hybrid repair of mycotic innominate artery pseudoaneurysm
11. 14:50 - 14:55
  
  A single-stage hybrid endovascular repair of symptomatic Type V thoracoabdominal aortic aneurysms: combined sandwich and debranching technique
12. 14:55 - 15:00
  
  Chimney endovascular aneurysm sealing (ch-EVAS) for ruptured abdominal aortic aneurysms due to Type Ia endoleak following failed EVAS
13. 15:00 - 15:05
  
  Endovascular management of a large iliac artery pseudo-aneurysm caused by a failing hip replacement prosthesis, case report and technical challenges
14. 15:05 - 15:10
  
  Endovascular repair of thoracoabdominal aortic aneurysm using the off-the-shelf multibranched t-Branch stent graft: the aneurysm shrinkage could influence visceral stents sealing causing bridging stents fracture and Type III endoleaks
15. 15:10 - 15:15
  
  Double-barreled cannon and branched stent-grafting for thoracoabdominal aortic aneurysm — the Hexapus technique
16. 15:15 - 15:30
  
  Discussion and conclusion
14:15 - 16:00, Room 5 - Global Expert Exchange

DEEP DIVE SESSION: Endovenous therapies – Part I

Moderator:

Nils Kucher, Stephen Black

Panel:

Steven Kum, Rick de Graaf
1. FOCUS ON IVC FILTERS
2. 14:15 - 14:22
  
  Pros and cons of IVC filter implantation: What are the established indications?
3. 14:22 - 14:27
  
  Challenging case: Massive thromboembolism trapped in IVC filter during total hip replacement arthroplasty
4. 14:27 - 14:34
  
  Tips and tricks for challenging and complex IVC filter
5. 14:34 - 14:39
  
  To worry or not to worry with a ruptured inferior vena cava post IVC filter removal
6. FOCUS ON DEEP VEIN RECANALISATION
7. 14:39 - 14:46
  
  CTV vs. MRV for imaging of venous disease
8. 14:46 - 15:01
  
  Recorded case presentation
9. 15:01 - 15:08
  
  Assessing the CFV – do I need to perform an endophlebectomy or not
10. 15:08 - 15:15
  
  Where to include IVUS in optimal venous diagnostic treatment pathway
11. 15:15 - 15:22
  
  Radiation dose in venous procedures how do we actively reduce this
12. 15:22 - 15:29
  
  Is there a place for endovascular therapy of acute venous thrombosis after ATTRACT?
13. 15:29 - 15:36
  
  Single session pharmaco-mechanical venous thrombectomy – how to do it!
14. 15:36 - 15:43
  
  Evidence on mechanical thrombectomy for iliofemoral DVT
15. 15:43 - 15:50
  
  Assessing adequate clot removal after lysis – when are you done and decision making in what stent
16. 15:50 - 16:00
  
  Discussion and conclusion
14:30 - 15:30, Room 7 - Speakers' corner

Selected abstracts original research – carotid/ iliac/ renal

Moderator:

Brian DeRubertis

Panel:

Eberhard Wedell, Ralph-Ingo Rückert
1. 14:30 - 14:35
  
  Open heart surgery or carotid endarterectomy. Which procedure should be done first?
2. 14:35 - 14:40
  
  Outcome of carotid artery stenting in patients with combined carotid and coronary artery disease
3. 14:40 - 14:45
  
  Transcarotid stenting with reverse flow neuroprotection is a safe and effective alternative to carotid endarterectomy for high-risk patients
4. 14:45 - 14:50
  
  Increase in serum S100B after carotid artery stenting and carotid endarterectomy
5. 14:50 - 14:55
  
  Assessment of long-term survival after carotid endarterectomy and carotid stenting in patients older than 80 years
6. 14:55 - 15:00
  
  Carotid angioplasty – current experience of a single Brazilian center
7. 15:00 - 15:05
  
  Comparison of hybrid and open surgery effectiveness in treatment of iliac occlusive disease (TASC C, D) and concomitant lesion of common femoral artery: Randomised clinical study, preliminary results
8. 15:05 - 15:10
  
  Verify the efficacy of renal artery stenting to define the predictive factors by physiological assessment with pressure wire gradient (VERDICT study)
9. 15:10 - 15:15
  
  A new treatment for chronic kidney disease: denervation in the collecting system with the Verve medical device
10. 15:15 - 15:30
  
  Discussion and conclusion
14:45 - 15:55, Scientific Posters

Challenging cases and original research: carotid and embolisation

Juror:

Steve Ramee, Giancarlo Biamino
1. 14:45 - 14:50
  
  The result of carotid stenting for different accesses
2. 14:50 - 14:55
  
  Hybrid repair of multilevel lesions of the brachiocephalic arteries
3. 14:55 - 15:00
  
  Bypass for symptomatic in-stent carotid restenosis
4. 15:00 - 15:05
  
  Single-center experience with MicroNet covered embolic prevention stent in a treatment of vulnerable carotid plaque: short and mid-term results
5. 15:05 - 15:10
  
  Transradial carotid artery stenting using Paladin system together with the double layer micromesh stent
6. 15:10 - 15:15
  
  Tracheo-innominate fistula diagnosis and treatment: A single center retrospective evaluation
7. 15:15 - 15:20
  
  A case of acute ischemic stroke with total occlusion of ipsilateral internal carotid artery and severe stenosis of petrous part of contralateral internal carotid artery15:20:00
8. 15:20 - 15:25
  
  Successful treatment of right subclavian artery stenosis by preservation of the carotid artery with distal protection device
9. 15:25 - 15:30
  
  Recurrent in-stent restenosis after subclavian artery stenting in a young female patient with Takayasu’s arteritis
10. 15:30 - 15:35
  
  Radial access for subclavian artery stenting
11. 15:35 - 15:40
  
  Unusual curative embolisation of the mycotic aneurysm of the inferior gluteal artery
12. 15:40 - 15:45
  
  Aneurysmal bone cyst embolization – an effective and safe endovascular approach. Case reports and literature review
13. 15:45 - 15:50
  
  Aneurysm of a splenic artery collateral
14. 15:50 - 15:55
  
  A complex embolisation procedure using AMPLATZER vascular plugs for internal iliac artery aneurysm with anatomical difficulties due to previous history of abdominal aorta replacement surgery
15:00 - 16:30, Room 1 - Main Arena 1

VIVA@LINC: Facing the future with a look 10 years forward

Moderator:

John Laird, Peter Schneider

Panel:

Dierk Scheinert, Krishna Rocha-Singh, Chris Metzger
1. 15:00 - 15:05
  
  Announcement of the winners of the Vascular Career Award 2017
2. 15:05 - 15:13
  
  Type B aortic dissection: Endovascular grafting will be required in most patients
3. 15:13 - 15:39
  
  Live case transmission from Teaneck
4. 15:39 - 15:47
  
  Drug-coated balloons: Will be used in every vascular bed, yes or no?
5. 15:47 - 15:55
  
  The breakthrough in complex tibial and pedal revascularisation will be….
6. 15:55 - 16:22
  
  Live case transmission from Teaneck
7. 16:22 - 16:30
  
  We will have agreed upon indications for repair of asymptomatic carotid atenosis, yes or no?
15:00 - 16:30, Room 2 - Main Arena 2

CX@LINC: aortic endovascular techniques at CX 2017

Moderator:

Roger Greenhalgh

Panel:

Tilo Kölbel, Dittmar Böckler, Andrew Holden
1. 15:00 - 15:05
  
  Welcome by panel
2. 15:05 - 15:15
  
  Video presentation: "Tips and tricks in aortic arch interventions"
3. 15:15 - 15:25
  
  Audience participation and discussion
4. 15:25 - 15:35
  
  Video presentation: “FEVAR case: how to reduce radiation exposure during complex endovascular repair” from S. Haulon presented by
5. 15:35 - 15:45
  
  Audience participation and discussion
6. 15:45 - 15:55
  
  Video presentation: “Technique for delivery of branched grafts during chimney or juxta-renal aortic procedures”
7. 15:55 - 16:05
  
  Audience participation and discussion
8. 16:05 - 16:15
  
  Video presentation: “Tips and tricks for on table imaging to detect EVAR endoleak”
9. 16:15 - 16:30
  
  Audience participation and discussion
15:00 - 16:30, Room 3 - Technical Forum

Focus session: Embolisation therapies and TIPS

Moderator:

Ulf Teichgräber

Panel:

Thomas J. Vogl, Maciej Pech, Walter Wohlgemuth, Boris Radeleff
1. 15:00 - 15:08
  
  Medium and long-term outcome of prostate artery embolisation for patients with benign prostatic hyperplasia
2. 15:08 - 15:29
  
  Live case transmission from Jena
3. 15:29 - 15:37
  
  TIPS Implantation: results and outcome in a liver transplant center
4. 15:37 - 15:45
  
  Value of cone-beam CT to identify anatomic variations for prostate artery embolisation
5. 15:45 - 15:53
  
  Endovascular treatment of arterial-venous malformations: Effectivness and safety
6. 15:53 - 16:14
  
  Live case transmission from Frankfurt
7. 16:14 - 16:22
  
  Interventional treatment of acute and chronic gastrointestinal bleeding
8. 16:22 - 16:30
  
  Beyond gastrointestinal bleeding – Tips and tricks for emergency coil embolisation in various locations
15:30 - 16:30, Room 4 - Discussion Forum

CICE@LINC: The role of mechanical thrombectomy in arterial and venous obstructions

Moderator:

Armando Lobato
1. Venous thrombectomy: greater effectiveness with lower risk!
2. Hemodialysis vascular access salvage with mechanical debulking device
3. Mechanical debulking – Is it effective in endograft iliac limb occlusion?
4. Mechanical thrombectomy in peripheral interventions: A multitask and effective tool in a widening scenario. Current evidence and technical tips.
5. Acute and subacute ischemia of the lower limb – Can mechanical debulking replace surgery and thrombolyses?
15:30 - 16:30, Room 7 - Speakers' corner

Selected abstracts challenging cases – CLI/PVD/SFA

Moderator:

Ramon Varcoe, Richard Heuser, Young-Guk Ko
1. 15:30 - 15:35
  
  Successful limb salvage in severe Buerger’s disease with aggressive endovascular approach
2. 15:35 - 15:40
  
  FemPop graft failure: Resurrection with the CrossLock™LP
3. 15:40 - 15:45
  
  Endovascular treatment for puncture site complication, inguinal hemorrhage, and incorrect puncture for internal jugular vein
4. 15:45 - 15:50
  
  Radial access with embolic protection device to remove organised thrombus of left upper brachial artery
5. 15:50 - 15:55
  
  Radial approach for CLI patient with unexpected trouble
6. 15:55 - 16:00
  
  EVT for Long SFA-CTO, usefulness of GIP method
7. 16:00 - 16:05
  
  Endovascular treatment of posterior Nutcracker syndrome
8. 16:05 - 16:30
  
  Discussion and conclusion
16:00 - 17:30, Room 5 - Global Expert Exchange

Deep dive session: Endovenous therapies – Part II

Moderator:

Gerard O'Sullivan, Erin Murphy

Panel:

Raghu Kolluri, Matthias Ulrich, Karin Brachmann
1. TOWARDS NEW VENOUS STENT DESIGNS: A DEVICE PARADE
2. 16:00 - 16:05
  
  VIVO EU and VIVO US: experience with the ZILVER VENA stent
3. 16:05 - 16:10
  
  Building clinical evidence: Update on the ABRE study
4. 16:10 - 16:15
  
  VENOVO® Venous stent – Update on the Vernacular trial
5. 16:15 - 16:20
  
  Patency rates and clinical results of the Venovo venous stent in a real world registry
6. 16:20 - 16:25
  
  Patency rates and clinical results of the Veniti VICI stent for the treatment of iliac vein lesion
7. 16:25 - 16:30
  
  The bifurcation stent: Sinus obliqus
8. 16:30 - 16:37
  
  Matching the right venous stent to your patient and their individual anatomy
9. 16:37 - 16:44
  
  How to use anatomical landmarks only to precisely position left common iliac venous stents at the IVC confluence
10. 16:44 - 16:51
  
  Re-intervention in venous stents – causes, identification, and solution
11. FOCUS ON SUPERFICIAL VENOUS DISEASE
12. 16:51 - 16:58
  
  Diagnostic workup prior to ablation therapy of superficial venous disease
13. 16:58 - 17:05
  
  VeClose trial: Cyanoacrylate closure vs. RF ablation 36-month results
14. 17:05 - 17:12
  
  Laser technology: latest developments
15. 17:12 - 17:19
  
  Managing the challenging patient: Ancillary procedures for complex anatomies
16. 17:19 - 17:30
  
  Panel discussion
16:30 - 18:00, Room 1 - Main Arena 1

The last frontiers: Endovascular therapy of the common femoral artery and the popliteal segment

Moderator:

Marc Bosiers, Lawrence Garcia

Panel:

Chris Metzger, Ulrich Beschorner, Ralph-Ingo Rückert, Martin Malina, Darren Schneider
1. 16:30 - 16:37
  
  Is it now time for endovascular techniques to conquer the CFA?
2. 16:37 - 16:42
  
  Complex stenting of the common femoral artery
3. 16:42 - 16:47
  
  Recanalisation of femoral bifurcations using the Culotte stent technique
4. 16:47 - 16:52
  
  The VMI-CFA study: A physician-initiated study investigating the Supera stent in the common femoral artery (preliminary 6-month results)
5. 16:52 - 17:15
  
  Live case transmission from Bad Krozingen
6. 17:15 - 17:20
  
  Drug-eluting treatments of the common femoral artery – the last frontier
7. 17:20 - 17:25
  
  Combined use of directional atherectomy and DCB for the treatment of the CFA: immediate and one-year outcomes
8. 17:25 - 17:50
  
  Live case transmission from Leipzig
9. 17:50 - 17:55
  
  DCB for popliteal artery stenosis: Update from the IN.PACT Flexion trial
10. 17:55 - 18:00
  
  Results from the 100 patients of the prospective TIGRIS Vienna study
16:30 - 18:00, Room 2 - Main Arena 2

Advanced techniques for challenging necks and solutions for endoleaks

Moderator:

Tilo Kölbel, Roberto Chiesa

Panel:

Dittmar Böckler, Jean-Paul de Vries, Reinhard Kopp, Ayman Al-Sibaie, Mauro Gargiulo
1. 16:30 - 16:36
  
  Combined technique (cHFEVAR) (chimney + fenestrated endograft) for complex aneurysm
2. 16:36 - 16:44
  
  Recorded live case: The fenestrated Anaconda endograft
3. 16:44 - 16:50
  
  Adaptation of the peri-renal aorta after placement of a AAA stent graft
4. 16:50 - 17:18
  
  Live case transmission from Münster
5. 17:18 - 17:24
  
  Changes in stent graft apposition and neck morphology post EVAR, CHEVAR, and FEVAR. Are there any differences?
6. 17:24 - 17:30
  
  3– 4x FEVAR vs. standard 2x FEVAR: expected advantages and potential risks
7. 17:30 - 17:36
  
  Routine closure of gutters with liquid polymer solves the Chimney problem and makes them as good as fenestrated grafts
8. 17:36 - 17:42
  
  100% of RAAAs can be treated by EVAR and adjunct techniques as Chimneys and Onyx embolisation – a single center study
9. 17:42 - 17:48
  
  Treatment options of late failures (particularly migration) of EVAS
10. 17:48 - 17:54
  
  Aneurysm sac filling: a new method to treat endoleaks
11. 17:54 - 18:00
  
  Transcaval embolisation of Type 2 Endoleak after EVAR
16:30 - 18:00, Room 3 - Technical Forum

Miscellaneous topics: Renal, visceral interventions, and beyond

Moderator:

Robert Lookstein, Iris Baumgartner-Peuker

Panel:

Dai-Do Do, Thomas Heller, Felix Mahfoud

Notice

LINC 2018 presentations

Conference day 1

SYMPOSIUM: Present and future clinical use for vascular mimetic stents

2-year data Supera popliteal real world

Supera in popliteal aneursym

Live case transmission from Leipzig

Preliminary 6-month results of VMI CFA trial

NEW DAWN: 1-year results of the combination DCBs and Supera stent for the treatment of long femoropoliteal lesions

Live case transmission from Leipzig

Acute deep vein thrombosis

Pharmacomechanical thrombolysis

Catheter-directed thrombolysis

Catheter treatment of DVT: What do the guidelines say?

The ATTRACT study: View from the U.S. expert

The ATTRACT study: View of a European expert

Live case transmission from Zurich

Live case transmission from Galway

Electronic posters will be displayed from 08:00 – 18:00 in front of Main Arena 1

Management of carotid artery disease: Remaining controversies and challenges ahead

Randomised data in carotid artery stenting: current evidence and future perspectives

Despite Level 1 and other evidence, the future outlook for carotid stenting is bright

The future of carotid stenting – Proximal protection and mesh-covered stents are the answer

Live case transmission from Berlin

1-year results of a new mesh-covered carotid stent: SCAFFOLD trial

The CLEAR-ROAD study: a physician-initiated study investigating the RoadSaver stent in carotid lesions (final 12-month results)

PrOspective multiCentrE study of cArotid artery steNting Using MER Stent – the OCEANUS study

Comparative analysis of new mesh-covered stent designs using MRI parameters

Plaque protrusion during carotic artery stenting: risk factors determined by MR plaque imaging

ROADSTER 2 trial: Transcervical access with reversed flow circuit for proximal protection during CAS. What have we learned so far?

Transcervical carotid stenting (TECAR) with flow reversal vs. CEA in highly symptomatic patients

THE GREAT DEBATE: HOW SHOULD WE HANDLE ASYMPTOMATIC CAROTID STENOSES?

Carotid repair is best for asymptomatic severe carotid stenosis because medical management alone does not work

When better NOT to treat asymptomatic carotid stenosis

ACST-2, over 2500 patients randomised; what do we know?

Discussion and conclusion

Latest results with new technologies for femoropopliteal obstructions: drug-eluting devices, atherectomy and new implants

EFFPAC–RCT: Final 6-months results with the Luminor DCB in femoropopliteal lesions

ILLUMENATE EU RCT: 2-year results with the Stellarex DCB in femoropopliteal lesions

FIRST TIME DATA RELEASE: CONSEQUENT RCT: 2-year results with the SeQuent Please OTW DCB

FIRST TIME DATA RELEASE: IN.PACT Japan RCT of DCB vs. PTA: 2-year results

FIRST TIME DATA RELEASE: ILLUMENATE GLOBAL: 2-year results of the Stellarex DCB in femoropoliteal lesions

DANCE trial (ATX and PTA groups) – 2-year results

Long term durability of DCB treatment in the SFA: 4-year results of the IN.PACT SFA study

Outcomes of DCB use in real-world patients: 2-year results from the IN.PACT global registry

FIRST TIME DATA RELEASE: LUTONIX long lesion study: 2-year outcomes

FIRST TIME DATA RELEASE: COMPARE-Pilot RCT: 1-year results of a randomised comparison of RANGER DCB vs. IN.PACT DCB in complex SFA lesions

FIRST TIME DATA RELEASE: Outcomes of DCB use in femoropopliteal lesions of patients with CLI (RCC4/5): Subgroup analysis of IN.PACT global study

PROMISE AND LIMITATIONS OF DCB – WHAT HAVE WE LEARNED?

DCB from a preclinical perspective: The relevance of paclitaxel dose and coating integrity

DCB from a clinical perspective: What is proven and where are the open questions and limitations?

Panel discussion

Update on the TOBA studies in the femoropopliteal arteries

FIRST TIME DATA RELEASE: LOCOMOTIVE All Comers Study with the VascuFlex Multi-LOC spot stenting device: 12-month results

FIRST TIME DATA RELEASE: 1-year results from the MIMICS-2 Study; US, German, and Japanese experience with the BioMimics 3D stent

Discussion and conclusion

Management of complex aortoliliac disease: Avoiding complications and optimizing outcomes

Endovascular treatment of occlusive aortic disease with abdominal stent grafts

Contemporary stenting of the abdominal aorta for steno-occlusive disease: new technical developments

Mid-term outcome of CERAB for aorto-iliac occlusive disease

Live case transmission from Cotignola

Experience after 500 endoluminal stent grafts. Devices specific outcome and lessons learned.

LIFESTREAM™ – First look at the BOLSTER two year follow up data

Improving the treatment of complex iliac occlusive disease: 24-month results from the VBX FLEX trial show sustained clinical benefits in complex patient subsets

Live case transmission from Leipzig

Prevention and management of vascular complications related to transcatheter aortic valve implantation

CCT@LINC

Introduction

Video live and lecture: How to cross below-the-knee CTO

Video live and lecture: How to cross below-the-ankle CTO

Video live and lecture: How to cross SFA CTO/Japanese evidences

Video live and lecture: How to cross SFA CTO/Japanese techniques

Discussion and conclusion

SYMPOSIUM: Patient first: “Leave the right thing behind”. Debating evidence to provide the answers

Introduction

XPEDITE study

DCB + BMS is not a DES

Live case transmission from Leipzig

Understanding restenosis in the SFA

First results of the ZILVERPASS study

Early results of the PERFORMANCE I study assessing the safety and feasibility of a 3-in-1 carotid stenting sytem with integrated embolic protection